Characterization of non-viral vectors for gene transfer: evaluation of size investigations through dynamic light scattering (DLS) to characterize by Leucht, Katharina
Friedrich-Schiller University Jena 
 
Faculty of biology and pharmacy 
Department of pharmaceutical technology 
 
 
 
 
 
 
 
 
 
 
 
Diploma thesis 
 
 
 
 
Characterization of non-viral vectors for gene transfer: 
 
Evaluation of size investigations through dynamic light scattering (DLS) to characterize 
various plasmid/non-viral vector associations 
 
 
 
 
 
 
 
Submitted by:   Katharina Leucht 
Matriculation number: 64292
II 
 
Structure 
Preface ..................................................................................................................................... IV 
Abbreviations ........................................................................................................................... V 
Abstract ................................................................................................................................. VII 
CHAPTER  I  –  THEORETICAL CONSIDERATIONS.................................................... 1 
1 Introduction ......................................................................................................................... 1 
2 Gene transfer ....................................................................................................................... 2 
2.1 Viral vectors ...................................................................................................................... 2 
2.2 Non-viral vectors .............................................................................................................. 2 
2.2.1 Polymeric carrier systems .......................................................................................... 3 
2.2.1.1 Polyethyleneimine (PEI) .................................................................................... 3 
2.2.1.2 Poloxamines ....................................................................................................... 5 
2.2.1.3 Poloxamers ......................................................................................................... 7 
2.2.2 Lipid carrier systems .................................................................................................. 8 
2.2.2.1 Cholesterol as helper lipid in gene therapy ........................................................ 9 
2.2.3 Cyclodextrins ........................................................................................................... 11 
3 Characteristics of the applied techniques ........................................................................ 17 
3.1 Dynamic light scattering (DLS) ...................................................................................... 17 
3.2 Zeta potential (ζ-potential) .............................................................................................. 18 
3.3 Transmission electron microscopy (TEM) ..................................................................... 20 
CHAPTER II  –  EXPERIMENTAL SECTION................................................................. 21 
4 Materials and methods ...................................................................................................... 21 
4.1 Materials ......................................................................................................................... 21 
4.2 Preparation and purification of pCMVβGal ................................................................... 21 
4.3 Preparation of the formulations ...................................................................................... 23 
4.3.1 bPEI / DNA .............................................................................................................. 23 
4.3.2 Poloxamine 304 / DNA ........................................................................................... 23 
4.3.3 PE6400 / DNA ......................................................................................................... 23 
4.3.4 rM-β-CD/DNA, rM-β-CD/cholesterol/DNA and rM-β-CD/DC-cholesterol/DNA. 24 
4.4 Dynamic light scattering (DLS) ...................................................................................... 25 
III 
 
4.5 Zeta potential (ζ-potential) .............................................................................................. 25 
4.6 Cryo-transmission electron microscopy (cryo-TEM) ..................................................... 25 
5 Results ................................................................................................................................. 26 
5.1 DNA ................................................................................................................................ 26 
5.1.1 Verification of the plasmid by gel electrophoresis .................................................. 26 
5.1.2 Evaluation of DNA concentration and purity by UV spectrophotometry ............... 26 
5.1.3 Size of DNA in different dispersants ....................................................................... 27 
5.1.4 ζ-potential of DNA in different dispersants ............................................................. 28 
5.2 bPEI/DNA ....................................................................................................................... 28 
5.2.1 Size of bPEI and bPEI/DNA complexes in different dispersants ............................ 28 
5.2.2 ζ-potential of bPEI and bPEI/DNA complexes in different dispersants .................. 29 
5.2.3 Size and shape investigations of bPEI/DNA complexes in water by cryo-TEM .... 31 
5.3 Poloxamine 304/DNA ..................................................................................................... 31 
5.3.1 Size of poloxamine 304 and its formulations in different dispersants ..................... 31 
5.3.2 ζ-potential of poloxamine 304 and its formulations in different dispersants .......... 34 
5.3.3 Size and shape investigations of poloxamine 304/DNA associations in Tyrode by 
cryo-TEM ................................................................................................................ 35 
5.4 PE6400/DNA .................................................................................................................. 35 
5.4.1 Size of PE6400 and PE6400/DNA formulations in different dispersants ............... 35 
5.4.2 ζ-potential of PE6400 and its formulations in different dispersants ........................ 37 
5.4.4 Size and shape investigations of PE6400/DNA formulations in Tyrode by cryo-
TEM ......................................................................................................................... 38 
5.5 rM-β-CD/DNA, rM-β-CD/cholesterol/DNA and rM-β-CD/DC-cholesterol/DNA ........ 38 
5.5.1 Size investigations of rM-β-CD, rM-β-CD/cholesterol and rM-β-CD/DC-
cholesterol before and after addition of DNA ......................................................... 39 
5.5.2 ζ-potential measurement of rM-β-CD/cholesterol/DNA and rM-β-CD/ DC-
cholesterol/DNA complexes .................................................................................... 44 
6 Discussion ........................................................................................................................... 46 
7 Conclusion .......................................................................................................................... 52 
Bibliography ........................................................................................................................... 53 
Declaration of originality ....................................................................................................... 59 
 
IV 
 
Preface 
The experimental part preceding the present work was carried out in the laboratory of galenic 
pharmacy of the University of Paris-Sud in Châtenay-Malabry. Due to the cooperation of 
Prof. Alfred Fahr of the Friedrich-Schiller University in Jena and Prof. Elias Fattal of the 
university Paris-Sud, I was allowed to perform my experiments in the research group of Prof. 
Elias Fattal. Thank you for having offered me such a great opportunity. 
Additional collaboration with Prof. Yves Fromes made it possible to carry out several 
preparation and examination processes at the institute of myology of the hospital 
Pitié-Salpêtrière in Paris. 
I would especially like to thank Caroline Roques. The present diploma thesis is associated to 
her dissertation. She strongly supported my work, fairly commented it and was always willing 
to constructively discuss the topic.  
Further thanks go to the whole work groups of Prof. Elias Fattal and Prof. Yves Fromes as 
well as to all the helping hands of both of these working sites. 
Further thanks go to my family and Martin Weber. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gera, august 2007                                                                                              Katharina Leucht
V 
 
Abbreviations 
2-HP-β-CD  2-Hydroxypropyl-β-cyclodextrin 
bPEI   Branched polyethyleneimine 
CD   Cyclodextrin 
CMC    Critical micellar concentration 
cryo-TEM  Cryo-transmission electron microscopy 
DC-cholesterol 3b-[N-(N’,N’-dimethyl-aminoethane)-carbamoyl]cholesterol 
DDAB   Dimethyldioctadecyl-ammonium bromide 
DLS   Dynamic light scattering 
DM-β-CD  Dimethyl-β-cyclodextrin 
DNA   Deoxyribonucleic acid 
DOPE   Dioleoylphosphatidylethanolamine 
DOTAP N[1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium-methyl-
sulfate 
DOTMA  N-[1-(2,3-Dioleyloxy)propyl]-N,N,N-trimethyl-ammonium chloride 
EO   Ethylene oxide 
EPO   Erythropoietin 
HDL   High density lipoprotein 
hG-CSF  Human granulocyte-colony stimulating factor 
LDV   Laser Doppler Velocimetry 
lPEI   Linear polyethyleneimine 
pCMVβGal Plasmid coding for the bacterial β-galactosidase driven by the human 
cytomegalovirus promoter 
PCS   Photon correlation spectroscopy 
PEI   Polyethyleneimine 
PEO   Polyethylene oxide 
PO   Propylene oxide  
PPO   Polypropylene oxide 
rM-β-CD  Randomly methylated-β-cyclodextrin 
SDS   Sodium dodecyl sulfate 
SEC   Size exclusion chromatography 
SPE-β-CD  Sulphobutylether-β-cyclodextrin 
TAE   Tris-Acetate-EDTA 
VI 
 
TEM   Transmission electron microscopy 
TM-β-CD  Trimethyl-β-cyclodextrin 
UE   Electrophoretic mobility 
 
VII 
 
Abstract 
Within this work, from a large amount of non-viral vectors available for gene transfer, some 
representative ones were chosen to be associated to the widely used reporter gene 
pCMVβGal. Polycationic bPEI, single positively charged poloxamine 304 and the non-ionic 
poloxamer PE6400 were applied as polymeric DNA carrier systems. Further non-polymeric 
formulations contained non-charged cholesterol or monocationic DC-cholesterol, both 
solubilized by randomly methylated β-cyclodextrins (rM-β-CD). As dispersants, water, NaCl 
0.45% and Tyrode’s solution were used. Size investigations of the resulting structures were 
performed through dynamic light scattering (DLS) to evaluate the utilizability of the 
technique in such concerns. 
It appears that the interaction behavior strongly depends on the physicochemical properties of 
the applied vector: for bPEI and poloxamine 304, both exhibiting strong electrostatic 
interactions with DNA, the method accurately describes the samples in various media and 
concentrations. The interaction potential between the plasmid and its complexation partner is 
clearly evidenced from the size distribution profiles that are different for DNA alone, the 
vector alone and the associates of both components. The hydrodynamic diameters of the 
PE6400, cholesterol or DC-cholesterol containing formulations strongly resemble the ones 
obtained for DNA alone. Since an overlay between the peaks of pCMVβGal and the vector 
may exist, the application of DLS as sole technique cannot clearly affirm the existence of 
interactions for theses dynamic structures. 
To round off the investigations, morphological cryo-TEM analysis and ζ-potential 
measurements were performed in addition. 
1 
 
CHAPTER  I  –  THEORETICAL CONSIDERATIONS 
 
1 Introduction 
So far a number of inheritable or acquired human pathologies such as genetic diseases, 
carcinomas and several infections are hardly treatable by conventional medicine. For those, 
the up-to-date therapeutic concept of gene therapy is expected to be a promising approach. 
Currently, the lack of efficient and non-toxic gene delivery systems constitutes a major hurdle 
to the successful application of that method. Hence, many efforts to improve the characteristics 
of the vectors were attempted and further examinations still continue on a grand scale.  
After administration, plasmid DNA (pDNA) has to overcome several barriers before reaching 
the nucleus of cells, where it finally needs to be expressed [1]. Since DNA is considered to be 
a large, fragile molecule, therapeutic genes must be protected from extra- and intracellular 
degradation by nucleases. Due to their size, their negative charge and the resulting 
hydrophilicity, plasmids further require to be formulated to facilitate their intracellular entry. 
Besides efforts to administer naked DNA through direct injection, particle bombardment      
[2, 3] or electroporation [4, 5], numerous gene delivery systems were introduced and 
evaluated. All those need a significant and reproducible characterization and their quality 
must be guaranteed by appropriate methods. 
For some representative examples of the variety of vectors we investigated the size 
distribution profiles through dynamic light scattering (DLS; also called photon correlation 
spectroscopy, PCS). The technique was chosen, since it constitutes a fast and simple method 
to measure the vector/DNA associations’ hydrodynamic diameters. We evaluated the utility 
the method for different gene delivery systems and examined its advantages and limits 
depending on the physicochemical properties of the formulations. To give a broad overview, 
we applied polymeric and non-polymeric systems. The polymers included a polycation, a 
single positively charged molecule and a non-charged compound, whereas the non-polymeric 
formulations contained non-charged cholesterol or a single positively charged cholesterol 
derivative that were solubilized by randomly methylated β-cyclodextrins (rM-β-CD). These 
vectors were associated to a widely used reporter gene, pCMVβGal, and characterized in 
different dispersants. Furthermore, we looked at other suitable techniques like zeta (ζ) 
potential measurement and cryo-transmission electron microscopy (cryo-TEM), providing 
additional information to complete our investigations.   
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2 Gene transfer 
A lot of approaches concerning the development of gene delivery vectors have been assessed. 
Those systems can be mainly divided into viral and non-viral vectors.  
2.1 Viral vectors 
DNA as well as RNA viruses own special molecular mechanisms to transfer their genomes 
into the nucleus of the infected cells. Thus, they provide an opportunity to transport genetic 
material within an organism in vivo or cell cultures in vitro. Retro-, adeno-, adeno-associated 
and herpes simplex viruses are commonly used examples. Due to their relatively high 
efficiency for both, DNA delivery and expression [6], they were widely investigated. Viral 
systems are still involved in many clinical trials, principally concerning cancer therapy [7, 8]. 
However, the DNA carrying capacity of viral vectors is restricted. Most of the systems cannot 
transport more than 10kb of exogenous DNA whilst the size needed to deliver complete loci 
can comprise over 100kb [9]. Recently, viruses that offer a larger gene carrying capacity have 
been introduced [9, 10], but further limitations including toxicity, potential immunogenicity, 
high costs and difficulties in production and packaging led to an increasing interest in non-
viral vectors in basic and clinical research [6]. 
2.2 Non-viral vectors 
Non-viral vectors can be classified into two main groups: lipids and polymers. Most of the 
synthetic gene delivery agents currently under development are positively charged to permit 
interactions with the phosphate backbone of DNA molecules which is deprotonated at 
physiological pH. Such non-viral systems offer a large diversity. Further variety exists due to 
the large number of available compositions and to the different methods of preparation. 
Moreover, synthetic vectors display no size limitation for the transgene and show relatively 
low immunogenicity. Toxicity depends on the used system as well as on its formulation.  
However, until now no system was introduced that approximately reaches viral vector’s 
efficiency. Therefore, current investigations are focused on the improvement of existing 
formulations and the development of new approaches.  
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2.2.1 Polymeric carrier systems 
Polymer-based vectors principally offer high diversity. From a great number of polymers that 
are available, we examined the following ones as models for gene delivery reagents of 
different charges: as a strongly positive charged molecule, branched polyethyleneimine was 
considered. Poloxamine 304, a so called Tetronic® macromolecule, was investigated since it 
displays one protonated amino group at a physiological pH and finally, poloxamer PE6400, a 
Pluronic® block copolymer that owns a non-ionic, amphiphilic structure, was examined as a 
non-charged compound.   
2.2.1.1 Polyethyleneimine (PEI) 
In gene delivery, polyethyleneimine (PEI) is mainly applied in two forms: as a branched 
(bPEI) and as a linear (lPEI) one. Depending on the linkage between the monomers, different 
structures occur. The branched isomer is synthesized by polymerisation of aziridine 
molecules, the linear one by cationic ring opening polymerisation of non- or 2-substituted 
2-oxazolines and subsequent hydrolysis of the corresponding N-substituted polymer [11, 12]. 
For several tissues, bPEI as well as lPEI have demonstrated some efficiency in vitro as well as 
in vivo [13]. bPEI has been the first cationic polymer reported as a vector for gene therapy. 
Since it has been extensively characterized in literature and as it is still used as a reference in 
many studies, we chose the compound as a model for highly positive charged systems. For its 
structure see figure 2.1.  
 
Figure 2.1: Chemical structure of branched PEI (adapted from Godbey et al. [11]). 
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The high density of positive charges leads to PEI’s capacity to spontaneously complex DNA. 
Polyelectrolyte complexes, formed mainly through electrostatic interactions between 
polycations and DNA, are called polyplexes. Their transfection efficiency depends on 
material properties as the molecular weight [14] and on complex characteristics such as the 
ratio between positive and negative charges (N/P ratio), DNA concentration and the method 
of preparation [15]. All those factors affect the particle size as well as the ζ-potential, which 
themselves are influencing transfection efficiency [16].  
Only cationic amino nitrogen will be involved in the electrostatic interactions between PEI 
and the negatively charged phosphate residues of the DNA backbone. The N/P ratio describes 
the ratio of PEI nitrogen atoms to DNA phosphates and hence indicates the amount of 
polymer used to form the complexes [16]. Boussif et al. found the N/P ratio of 9 to be most 
promising, since they obtained best transfection efficiency under such conditions [15]. As it 
was demonstrated, about every 6th nitrogen atom of bPEI is protonated under physiological 
conditions. A ratio of 9 would indicate a mean cationic charge excess of about 1.5, whilst 
such low charge densities have been shown as favorable for in vivo considerations [15, 17]. 
Since those first experiments, several ratios have been tested and classically, in the literature, 
an N/P ratio between 6 and 10 is used.  
PEI/DNA polyplexes enter cells via endocytosis [18]. PEI contains primary, secondary and 
tertiary nitrogen atoms, whereof each can be potentially protonated. This leads to a high 
buffering capacity in the endosomal environment over a wide range of pH [15]. Thereby, 
osmotic swelling of the vesicles is caused, which finally leads to their rupture and to the 
polyplexes’ release into the cytoplasm. This mechanism avoids the fusion of endosomes with 
lysosomes and hence protects DNA from being exposed to lysosomal DNase degradation 
[16]. The described mechanism of endosomolysis is well known as ‘proton sponge’ 
hypothesis [19]. 
When first reported as gene delivery vectors, PEI/DNA complexes were examined to display 
low in vitro toxicity. Whilst an N/P ratio of 9 was determined as favorable concerning 
transfection efficiency, only very positively charged complexes (N/P > 90) showed cytotoxic 
properties [15].  Nevertheless, permeabilizing effects of PEI on Gram negative bacterial outer 
membranes [20] and restricted cell function and viability [12] were described later. Recently, 
Boeckle et al. showed that unbound PEI contributes to cellular and systemic toxicity [21]. 
They used size exclusion chromatography (SEC) to purify PEI from the uncomplexed 
compound which led to decreased toxic effects in vivo and in vitro. In contrast, they 
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demonstrated free PEI to influence the vector’s transfection efficiency positively, since it was 
increased when such non-complexed molecules were present.  
Gharwan et al. investigated bPEI for intrauterine gene delivery into livers of fetal mice in the 
last trimester of pregnancy [22]. For bPEI/DNA complexes at an N/P ratio of 6, only 24% of 
the fetuses survived the treatment. However, it must be kept in mind that delivery into fetuses 
always causes additional problems and that it is even more delicate than any other way of 
administration. After having injected polyplexes at a N/P ratio of 10 into the pericardial sac of 
wild type Syrian hamster, 5 of 6 animals died within one hour [23]. These findings indicate 
that in vivo PEI cannot be regarded as a little-toxic non-viral vector.  
 
As low cationic charge density should be favorable for in vivo experiments, monocationic and 
non cationic polymers were investigated and evaluated as gene delivery systems. Thus 
poloxamines and poloxamers, two families of amphiphilic surfactants used in several 
biomedical research fields [24], have been considered for gene therapy. 
2.2.1.2 Poloxamines  
Also named as N,N,N',N'-tetra[(oxyethylene)-(oxypropylene)]diaminoethylenes, ethylene 
diamine alkoxylates or Tetronics® [25], poloxamines comprise a group of amphiphilic 
tetrafunctional AB block copolymers. Their chemical structure shows a central ethylene 
diamine, whereof each nitrogen atom is connected to two blocks consisting of polymerized 
ethylene oxide (EO) and propylene oxide (PO), respectively. Polyethylene oxide (PEO, the 
A-block) appears as particularly hydrophilic, whereas polypropylene oxide (PPO, the 
B-block) forms the more hydrophobic part of the molecule. Their general structure is 
described on figure 2.2.  
 
 
                            PEO               PPO     
               HO (CH2 CH2 O)x  (CH CH2 O)y                                  (PO)y  (EO)x 
                                              CH3                       N CH2 CH2 N          
                                          (EO)x  (PO)y            (PO)y  (EO)x 
 
Figure 2.2: General molecular structure of poloxamines (adapted from Moghimi and Hunter [24]). 
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Even though such compounds are usually considered as non-ionic surfactants, at physiological 
pH one of the nitrogen atoms is protonated, generating a mono cationic charge [25]. Several 
poloxamines that vary in both the PPO and PEO chain's length are available, leading to 
different molecular weights of the polymers. They range from 1,650 to 30,000Da which 
results in diverse surfactant consistencies such as viscous and oily or solid and amorphous 
characteristics [25]. 
As amphiphilic copolymers, poloxamines spontaneously aggregate in aqueous solutions after 
having exceeded the critical micellar concentration (CMC). Nanosized colloids are formed, 
which feature a hydrophobic core surrounded by a hydrophilic shell [26] and can therefore be 
used as carriers for poorly water soluble or amphiphilic drugs. For poloxamine T701 [25] and 
T904 [27], micellization is facilitated after deprotonation of the central diamine group. In this 
case coulombic repulsion forces among the positively charged molecular centers are strongly 
decreased and thus, they cannot hinder aggregation. However, an increase of the pH-value is 
not the only possibility to promote micellization. Further opportunities to minimize the 
hydrophilic properties of the copolymers and thereby to increase aggregation tendency are a 
rise of temperature and an augmentation of ionic strength. Added ions shield electrostatic 
repulsion and cause a small salting-out effect which diminishes poly(ethylene oxide) block's 
hydrophilicity and promotes hydrogen bonding interactions [27].  
Besides the described range of application, poloxamines were recently investigated as 
potential gene delivery systems. At physiological pH, the single positive charge of 
poloxamines allows interactions with polyanionic DNA molecules [28, 29]. Complexation 
happens due to electrostatic forces, whereas hydrogen bonding and hydrophobic interactions 
are involved as well. Poloxamines may be directly associated to DNA or after adsorption onto 
nanoparticles through its hydrophobic PPO segments [30, 31].  
When using a Tetronic® compound of relatively low molecular weight (poloxamine 304) to 
directly complex DNA, the formation of negatively charged DNA/poloxamine 304 
nanospheres takes place. In vivo comparison to the transfection efficiency of naked plasmids 
demonstrated luciferase expression to increase by 17 or 30-fold when 5 or 10% (w/v) of 
poloxamine 304 is present in the formulations [29].  
Within our work, such direct association of vector and DNA was of interest. Thus, we 
concentrated on formulations as used by Pitard et al. and focused on Tetronic® 304 which 
was examined by them as the best DNA complexing agent [29]. 
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2.2.1.3 Poloxamers 
Poloxamers or Pluronics® represent a group of non-ionic block copolymers that have already 
been utilized as excipients in formulations as gels, w/o and o/w emulsions, nanoparticles 
coated by the polymers or solid blends [32]. Furthermore, they have been evaluated and 
successfully used in gene therapy [28, 33, 34]. 
Like poloxamines, poloxamers are composed of relatively hydrophobic PPO and hydrophilic 
PEO, but arranged in a linear way. The resulting basic A - B - A structure is displayed on 
figure 2.3.  
 
 
       PEO    PPO   PEO 
HO (CH2 CH2 O)x  (CH CH2 O)y  (CH2 CH2 O)x   H 
             CH3 
Figure 2.3: General molecular structure of poloxamers (adapted from Kabanov et al. [35]). 
 
The number of the blocks’ EO and PO units is alterable, leading to variations in the properties 
of the compound. The synthesis of the polymers can be performed by sequential addition of 
PO and EO monomers in the presence of sodium or potassium hydroxides as an alkaline 
catalyzer [32].  
Pluronics® exhibit similar aggregation properties as Tetronics® and are able to form polymeric 
micelles with a core-shell architecture as well. In the same manner, the hydrophobic PPO core 
is separated from the aqueous solution surrounding the system by its hydrophilic PEO chains 
that compose the micelle's outer layer. The described structure offers carrying capacities for 
several therapeutic or diagnosis reagents and thus, increased solubility, improved 
pharmacokinetic behavior or augmented stability of the incorporated compounds can be 
reached. Such micellization occurs at polymer concentrations above the CMC. Depending on 
the PPO and PEO chain's lengths, spherical, rod-like or lamellar structures will be observed. 
As for Tetronic® copolymers, temperature and ionic strength of the surrounding medium are 
important factors influencing the structure of the micelles [32]. 
Poloxamers and DNA are hold together by relatively weak forces such as hydrogen bonding, 
since the copolymer does not display any charges to permit complex formation due to 
electrostatic interactions. Examined by Lemieux et al., the non-ionic carrier SP1017, a mixture 
of the two amphiphilic Pluronic® block copolymers L61 and F127, was shown to increase the 
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expression of luciferase and β-galactosidase plasmid DNA after intramuscular injection by 
about 10-fold when compared to naked DNA [28]. Since acute intravenous toxicity occurred 
to rats at about 5000-fold higher doses [36] than found to be optimal in the reported 
intramuscular experiments [28], SP1917 formulations were considered as relatively safe. The 
low amount of DNA, needed to achieve a significant increase in gene expression, is a further 
advantage, as it will lead to a low extent of unwanted immune response. 
Later, Pluronic® PE6400, another block copolymer of the poloxamer family, was reported to 
be efficient as an in vivo promoter of gene delivery to skeletal and cardiac muscles [33]. The 
level of plasmid expression was comparable to the one reached via electrotransfer, a method 
that had already been applied successfully to muscles before [4]. In comparison to the results 
obtained with naked DNA, luciferase activity was increased by 20 to 30-fold after having 
injected formulations containing 0.05 to 0.5% (w/v) of PE6400 [33]. Further experiments 
describe the inducible production of erythropoietin (EPO), a glycoprotein hormone, by using 
intramuscular injection of PE6400/DNA formulations [34]. The hematocrit increased up to 
75% and when compared to control mice, the EPO expression rate was 10-fold higher. The 
augmented number of red blood cells lasted up to 4 months.  
As it seems to be an auspicious gene delivery vector, we chose PE6400 as a model of 
non-ionic polymer for our investigations. 
2.2.2 Lipid carrier systems 
Lipid-based gene delivery vectors are colloids as liposomes and lipid emulsions [37, 38].  
Felgner et al. were the first to use a synthetic, cationic lipid, N-[1-(2,3-dioleyloxy)propyl]-
N,N,N-trimethyl-ammonium chloride (DOTMA), to carry genes into cells through liposomal 
delivery [39]. Since then, different research groups tested a great amount of lipids and further 
efforts for grading up transfection efficiency were made. Although liposomes in neutral and 
anionic forms are considered to be less toxic than their cationic counterparts, attention has 
been focused on positively charged formulations, due to their higher transfection and gene 
expression rate. A non-negligible disadvantage concerns the little stability of liposome-DNA 
complexes since liposomal formulations have been shown to aggregate or flocculate after 
addition of DNA molecules [40]. Therefore, the higher stability of lipid emulsions is seen to 
be a beneficial property for their use as non-viral vectors. They are well producible in an 
industrial scale and appear stable during storage [37].  
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Both systems displayed interesting results in vitro, but liposomes as well as DNA/lipid 
complexes often exhibit reduced transfection efficiency in vivo [41]. Furthermore, several 
toxic effects have been reported. As an in vitro example, lipoplexes containing 
dimethyldioctadecylammonium-bromide (DDAB), dioleoylphosphatidylethanolamine 
(DOPE) and the commercial transfection-reagent DOTAP (N[1-(2,3-dioleoyloxy)propyl]-
N,N,N-trimethylammonium-methylsulfate) were shown to exhibit cytotoxic features to the 
human carcinoma cell line CaSki, including cell shrinking, mitosis number reduction and 
vacuolization of the cytoplasm [42]. 
2.2.2.1 Cholesterol as helper lipid in gene therapy 
When compared to viral vectors, the relatively low transfection rate of liposomal systems 
remains problematic. Adding cholesterol, a micelle forming helper lipid [43], to the 
formulations, is one approach to ameliorate their efficiency. Köster et al. found that 
cholesterol containing DOTAP liposomes display 2.8-fold higher transfection efficiency in 
the human breast cancer cells line T-47D than their conventional counterparts [44]. According 
to them, other steroids exhibit similar effects, since they act through intracellular steroid 
receptors migrating from the cytosol to the nucleus upon activation. Thus, the transfected 
DNA might be co-transported to the nucleus. Even though cholesterol does not activate such 
specific intracellular receptors, it shifts the exogenous DNA from the cytosol to the nucleus. It 
is well known that membrane fluidity is influenced by its cholesterol content which could be 
seen as one reason for the enhancement of efficiency. Furthermore, cholesterol is commonly 
added to liposomes since it stabilizes the lipoplexes, protects them from serum influences and, 
thus, increases their in vivo transfection rate [45]. Liu et al. reported that cationic, 
multilamellar vesicles which incorporate cholesterol as neutral helper lipid increase the 
efficiency of cationic liposome:DNA complexes [46]. Using the luciferase reporter gene, they 
found a 1.7-fold increased expression rate, whilst it was even augmented by 569-fold when 
testing human granulocyte-colony stimulating factor (hG-CSF). Thereby, the latter value 
corresponds to prolonged circulation time of the liposomal system and to augmented uptake 
and retention in tissues. The level of gene expression in the lung was significantly higher than 
in the liver, indicating strong tissue dependence. 
As cholesterol and its derivatives are hardly soluble in aqueous solution, Lawrencia et al. 
added cyclodextrin (CD) solubilized 3β-[N-(N’,N’-dimethyl-aminoethane)-carbamoyl] 
cholesterol (DC-cholesterol) to their liposomal DOTAP formulations [47]. After the 
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incorporation of a pCMVβGal reporter gene into the murine urothelial cell line MB49, in 
vitro transfection efficiency increased by 3.8-fold compared to DOTAP alone. Thereby, in the 
presence of randomly methylated β-CD (rM-β-CD) and cholesterol, the majority of the 
complexes were detected in the nucleus, but they were also located in the cytoplasm. When 
DOTAP alone was used, the plasmid was only found in the cytoplasm, indicating the presence 
of rM-β-CD/cholesterol influence the escape of DNA from endosomes and to facilitate 
nuclear uptake. In vivo, DOTAP itself did not show efficient transfection of bladder epithelia. 
In contrast, after intravesical introduction of the formulations containing rM-β-CD/cholesterol 
into mice’s bladders, β-galactosidase activity was detectable up to 30 days. Since exposure of 
cells to rM-β-CD/cholesterol before transfection via DOTAP/DNA systems led to improved 
efficiency as well, the beneficial effect of the investigated complexes may be primarily due to 
an increase of membrane fluidity and permeability.  
Particularly the last approach seems very interesting and we chose to investigate cholesterol 
within our work. It had to be solubilized by CDs as described before [44, 47]. We decided to 
examine the complexes’ properties not only in regard to several dispersants, but also to 
differently charged derivatives of the molecule. Thus, cholesterol was chosen as a non-ionic 
compound as well as DC-cholesterol which displays a single positive charge and may 
therefore show enhanced interaction potential with the anionic phosphate backbone of DNA. 
For their chemical structures see figure 2.4. 
 
 
 
 
 
 
 
 
Figure 2.4: Chemical structures of a) cholesterol and b) DC-cholesterol (adapted from Avanti Polar Lipids). 
 
Since CDs constitute an important factor in such investigations, they will be now discussed in 
detail. 
a b 
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2.2.3 Cyclodextrins 
CDs comprise a family of cyclic oligosaccharides, whereof several members are widely-used 
for pharmaceutical concerns as well as in different sectors like agriculture, food industry and 
cosmetics [48]. The three natural molecules, α-CD, β-CD and γ-CD, are respectively built up 
from 6, 7 or 8 D-(+)-glucopyranose subunits. The chemical structure of β-CD is shown in 
figure 2.5a. Generated by degradation of starch via the enzyme glucosyltransferase, they are 
linked by α-(1,4)-glycosidic bonds [48] and form conically shaped cylinders (see figure 2.5b). 
As a consequence of the described conformation, all the primary hydroxyl groups are located 
at the narrower of the two ring borders, whereas all the secondary ones are placed on the 
wider side (figure 2.5c) [49]. All these hydrophilic groups are orientated towards the outer 
surface of the molecule, whilst oxygen atoms, forming hydrogen and glycosidic bonds, point 
within the cavity. Accordingly, a water compatible exterior and a hydrophobic pore are 
generated [48, 50]. In figure 2.5d, the approximate dimensions of natural CDs are shown [49]. 
  
 
 
Figure 2.5: Schematic representation of β-CD: a) chemical structure, b) toroidal shape (both adapted from Challa 
et al. [51]) and c) constitution of primary and secondary OH-groups (adapted from Davis and Brewster [52]).    
d) Geometric dimensions of α-, β- and γ-CD (adapted from Szejtli [49]). 
 
a b c 
  α-CD          β-CD            γ-CD 
d 
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Due to their unique structure, cyclodextrins are able to form inclusion complexes with various 
compounds or at least with some of their hydrophobic parts. When dissolved in an aqueous 
solution, the cavity of CDs is filled with polar water molecules, resulting in an energetically 
unfavorable state. For this reason, water can be easily substituted by less hydrophilic 
compounds, so called guest molecules, and without covalent linkages inclusion complexes are 
formed. Several host-guest ratios, like 1:1, 1:2, 2:1, 2:2, etc., are possible. Association and 
dissociation of CDs and their guests can be described by the thermodynamic equilibration (1), 
where G symbolizes the guest molecule and CD·G illustrates the complex. 
 
                   CD G CD G+ ⋅⇌                                                   (1) 
 
For a G:C ratio of 1:1, the complex stability constant K is calculated by equation (2). 
  
                                                             1:1
[ ]
[ ] [ ]
CD GK
CD G
⋅
=                                                      (2) 
 
Low water affinity of several drugs often causes problems in their administration. After 
having discovered that compounds can be dissolved easier when cyclodextrins are added to 
the solutions, their disposition to increase the apparent solubility of lipophilic drugs was 
widely analyzed. The cavity size of α-CD is insufficient for the majority of drugs and γ-CD is 
expensive. Hence, β-CD was widely used in the earlier stages of pharmaceutical applications, 
although its water solubility is quite low (18.5 g/l) compared to the α- and the γ-derivates (145 
and 232 g/l, respectively) [49, 51]. As a reason, the formation of an intra-molecular hydrogen 
bond network between the secondary hydroxyl groups is mentioned. Substituting some of 
these functional elements leads to an increased solubility, which is caused by disruption of the 
responsible linkages. Such chemically modified CDs are the results of etherification or 
introduction of other functional elements at the three hydroxyl groups of each glucose 
subunit. The methylated derivates dimethyl-β-CD (DM-β-CD), trimethyl-β-CD (TM-β-CD) 
and randomly methylated β-CD (rM-β-CD) as well as 2-hydroxypropylated β-CD 
(2-HP-β-CD) and sulphobutylether-β-CD (SPE-β-CD) are just some examples for available 
molecules [48]. Several formulations containing cyclodextrins and utilizing their solubilizing 
effect are already introduced onto the market. Thereof the following shall be mentioned 
exemplarily: Nicorette®microtab (Nicotine, sublingual tablet, containing β-CD, [53]), 
Aerodiol® (17β-Oestradiol, nasal spray, rM-β-CD, [54]) and Voltaren®ophta CD (Diclofenac 
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sodium, eye drops, 2-HP-γ-CD, [55]). Further examinations also consider their use in peptide, 
protein and oligonucleotide delivery [51]. 
To study CD inclusions complexes, the phase solubility method of Higuchi and Connors [56] 
has been widely used. By this approach, the effect of the solubilizer, CD in our case, onto the 
drug being solubilized, e.g. cholesterol, is examined [51]. Such phase solubility diagrams are 
obtained as follows: excess amounts of the guest molecule are added to a constant volume of 
aqueous solutions containing increasing concentrations of CDs. After reaching the 
equilibrium, the non-solubilized drug molecules are removed and the amount of the dissolved 
guest molecules is determined. 
This phase solubility method allows the description of two types of curves: an A type, 
denoting the formation of soluble complexes, and a B type for the less soluble ones. Both are 
divided into several subtypes: the A curves are classified into AL systems, signalizing linear 
increase of drug solubility as a function of CD concentration, and further into AP and AN 
subtypes for positively or negatively deviating isotherms. BS curves indicate limited 
solubility, whilst complexes showing BI behavior are insoluble. An illustration is given on 
figure 2.6.  
Due to its low solubility, β-CD often gives B type curves, whereas α- and γ-, as well as 
chemically modified CDs like rM-β-CD mainly show A type behavior [51]. When following 
an AL or AN comportment, drugs will not precipitate through dilution of the formulations. In 
contrast, a precipitation of the CD’s guest molecule may occur if an AP correlation between 
drug solubility and CD concentration exists. 
By this method, stoichiometry of guest/CD complexes and the numeric value of their stability 
constant can be obtained, indicating the technique as very useful in such complexes’ 
characterization. 
 
Figure 2.6: Theoretical phase solubility diagram (adapted from Challa et al. [51]). SO symbolizes the intrinsic 
solubility of the drug studied under the conditions. 
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CDs as well as their complexes show self-association in solution and form aggregates of two 
or more CD molecules or complexes, respectively. During the last 15 years, this phenomena 
has been studied and proved by several methods [57-60], whereas Coleman et al. were the 
first to report the existence of assemblies of natural CDs after DLS investigations [57]. 
González-Gaitano et al. [58] also used DLS to study the association of CDs themselves, 
without the presence of guest molecules. According to their investigations, for rM-β-CDs 
aggregates of 120nm and monomers of 1.7nm were found. Such an assembly takes place very 
fast. The aggregation tendency of this methylated CD derivative was less obvious than for 
non-substituted CDs. It was concluded that such an assembly is associated with the presence 
of free OH groups at the rims of the CD molecules.  
Recently, a further study of β-CD’s aggregation behavior was published, using cryo-TEM and 
DLS [59]. As for the DLS examinations, a 3mM (0.34% w/v) sample as well as samples of 9 
(1.02% w/v) and 12mM (1.32% w/v) showed a mean hydrodynamic diameter of about 
180nm. Several samples accessorily displayed some particles as large as a few micrometers. 
Cryo-TEM experiments of 3mM solutions pointed out the existence of small globular 
particles with a mean diameter of about 6nm. These particles can form aggregates, displaying 
a branched appearance. Furthermore, disc-shaped structures were detected in the 
formulations, whereof some showed connections to each other via their edges.  
Loftsson et al. used the phase solubility method as described above to characterize CDs 
complexes [60]. They tested several CD derivatives combined with different molecules to be 
solubilized. Cholesterol showed highest affinity for the most hydrophobic of the investigated 
CD derivatives such as rM-β-CD. Thereby, such a host-guest combination is of particular 
interest in our work. The curve for cholesterol associated to rM-β-CD cavities was found to 
show a positive deviation from linearity and thus, an AP profile was suggested. These results 
indicate the formation of higher-order inclusion complexes.  
CDs are known to interact with biological membranes and to display the opportunity of 
modifying their cholesterol content. They are able to remove phospholipids [61] and proteins 
[62] from cell membranes, but in vitro mainly a high affinity for cholesterol was reported 
[63]. Especially β-CD was mentioned to own relative selectivity for cholesterol, leading to the 
idea of using these compounds as effective modulators of cholesterol metabolism in vivo [63].  
By the application of CD formulations, a cholesterol efflux from membranes may occur, 
rending such biological barriers more permeable. Kilsdonk et al. [63] examined 10mM β-CD, 
2-OH-β-CD and rM-β-CD, respectively, to induce the release of 50-90% of L-cell cholesterol 
within 8h of incubation. They stated CDs to be more efficient cholesterol acceptors with high 
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potential for each investigated cell type than high density lipoprotein (HDL). The theory of 
cholesterol molecules that desorb from a membrane and diffuse directly into the hydrophobic 
cavity of CDs without total desorption into the aqueous environment, may serve as an 
explanation [61]. For incorporation into HDL, complete transfer into the aqueous phase, a 
diffusion step and final solubilization by the acceptor molecule is necessary.  
Since exhibiting cell toxicity due to resulting membrane instability, such decline of 
membrane’s cholesterol content can be seen as a disadvantage. However, in gene therapy it 
may also constitute a chance to facilitate the entry of DNA into cells. Christian et al. 
described further interesting observations [64]. They used CD/cholesterol complexes to 
modify cell cholesterol content and reached net depletion as well as net enrichment. For 
rM-β-CD, the membrane’s sterol amount was not modified when solutions of a molar 
rM-β-CD/cholesterol ratio of 8:1 were applied. When saturated with cholesterol, the CD 
formulations exhibited cell cholesterol increase, whilst, when containing less cholesterol, a 
diminution occurred that renders the membranes more permeable.  
Polymeric derivates of cyclodextrins are widely used as CD containing formulations for gene 
transfer. Two main types are applied: polymers prepared with non charged CDs, complexed to 
an ionic guest molecule acting as a linker between the CD polymer and DNA (see figure 2.7) 
[65, 66], and polymers based on polyamino derivates of CD, displaying positive charges 
themselves [67].  
 
 
 
Figure 2.7: Schematic representation of ternary complex formation between poly-βCD, a cationic guest molecule 
and DNA (adapted from Galant et al. [66]). 
 
But also monomeric CDs have already been reported as gene delivery vectors, an approach 
that will be referred to in our work [47].  
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For all therapeutic concepts, safety represents a primary concern and toxicological studies are 
of major interest. Prior examinations demonstrated mainly the parent CDs to be hemolytic 
[63] and nephrotoxic [62]. As the kidney remains the main elimination organ of CDs from 
systemic circulation, they are concentrated in the proximal tubule after glomerular filtration. 
Thereby, the nephrotoxicity corresponds to a series of variations in the vacuolar organelles of 
the proximal convolute [62]. As variations of CD’s hydroxyl substituents may result in 
increased hydrophilicity and greater solubility, such derivatives exhibit reduced renal toxicity. 
Concerning methylated CD derivates, in vitro toxicity was assessed for several cells types. 
Administered on a buccal way, rM-β-CD shows increasing toxicity as concentration and time 
exposure were heightened, but can be considered as relatively safe when used at levels below 
5% (w/v) [68]. In an intestinal cell culture model, DM-β-CD exhibited insignificant toxicity 
for the human colorectal carcinoma cell line Caco-2 [69]. Furthermore, in vitro safety of nasal 
formulations containing CDs as an absorption enhancer could be confirmed [70]. Since in 
vitro, influencing factors such as drainage, dilution and systemic conjunctival absorption are 
absent, and in vivo, administration is generally seen to be more complex, the described 
indication is not directly assignable to in vivo conditions. 
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3 Characteristics of the applied techniques 
3.1 Dynamic light scattering (DLS) 
To analyze the size distribution of several nanosized therapeutic systems, DLS measurements 
may be applied. In liquids, every particle underlies a casual movement into the three 
directions in space, intensified by effects due to collision with and repulsion by their 
surrounding molecules. Such behavior is called the Brownian motion. Thereby, small 
particles move faster than large ones, permitting the calculation of the hydrodynamic diameter 
of the sphere that diffuses light as fast as the particle being measured. The principle is based 
upon irradiating the particles by a laser and analyzing the intensity variations of the scattered 
light. Size and Brownian motion are related by the equation of Stokes-Einstein (3), whereas 
the hydrodynamic diameter of the particle (d) may be calculated by its inverse proportionality 
to the coefficient of diffusion (D).  
                                                          
3
Bk TD
dpi η
=                                                                  (3) 
 
kB represents the Boltzmann constant (kB = 1.38·10−23 J/K), T marks the absolute temperature 
and η describes the dynamic viscosity. Within the instrument, a digital correlator is included 
which basically measures the degree of similarity of two signals over a certain time segment 
and displays a correlation function. From these measurements, the apparatus calculates the 
diffusion coefficient of the particles in the sample. Hence, their hydrodynamic diameter may 
be derived [71, 72]. A scheme of the measurement principle is given on figure 3.1. 
 
 
Figure 3.1: Scheme of the DLS measurement principle (adapted from Malvern, Zetasizer nano users manual). 
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The Z-average size (also called as the cumulants mean) is the most stable parameter produced 
by the DLS technique. It is only usable and comparable to other techniques if the sample is 
monomodal (displaying only one peak), spherical, and monodisperse. The cumulant analysis 
gives access to a mean size value and a width parameter (polydispersity index, PDI). The 
Z-average size is likely to be interpreted incorrectly if the distribution is broad and the system 
displays high polydispersity. For low polydispersity (< 0.1) the cumulant analysis will give a 
good description, well comparable to other techniques. The results may still be used for 
comparative purposes when the PDI is increased up to 0.5. At values above 0.5 it is not 
advisable to rely on the Z-average size. 
3.2 Zeta potential (ζ-potential) 
The ζ-potential offers a method to describe the apparent net charge of a particle, caused by 
ionization of the molecules’ surface groups. Direct measurement of the Nernst potential, 
corresponding to the surface charges, is not possible. When introducing a particle in aqueous 
solution, counter ions will bind to the particle’s surface to compensate the potential difference. 
Thus, a fix electrical double layer (Stern layer) surrounds such particles. Within the outer 
layer the ions are more diffuse. At a certain distance from the surface a boundary is reached. 
Within, the ions move with the particle being in motion and beyond, they do not travel with it. 
The potential existing at this boundary is known as ζ-potential. For a scheme see figure 3.2.  
 
 
 
Figure 3.2: Schematic representation of the ζ-potential (adapted from Malvern, Zetasizer nano users manual). 
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The extent of this potential may serve as an indicator of the stability of a colloidal system, 
since, when all particles own high positive or negative charges, they exert repulsive forces on 
each other and are therefore hindered to flocculate or even aggregate. -30mV or +30mV, 
respectively, are generally seen as borderlines between stable and unstable states. 
To measure the ζ-potential, an electric field needs to be applied to the formulations. The 
particles will be attracted by the electrode of opposite charge, whereas they are kept back by 
forces due to the surrounding medium’s viscosity. When these two processes are equilibrated, 
the particles move at constant speed (velocity) expressed as electrophoretic mobility (UE). 
When applying the Henry equation (4), the ζ-potential can be calculated as follows:  
 
                                                     
2 ( )
3E
f kaU ε ζ
η
=                                                            (4) 
 
Thereby,  ε describes the dielectric constant of the sample, ζ marks the ζ-potential, f (ka) 
constitutes the Henry equation and η symbolizes the dynamic viscosity. Since the ζ-potential 
is commonly obtained from aqueous solutions at moderate ion concentrations, f (ka) is 
indicated as the Smoluchowski approximation and therefore has a value of 1.5 [73, 74]. 
In our laboratory the Zetasizer Nano ZS (Malvern, Worcestershire, England) is used to 
perform such measurements. The instrument applies Laser Doppler Velocimetry (LDV) to 
measure UE. The incident laser beam gets scattered by the particles dispersed in the liquid. 
Detected in a 17° angle, the scattered light is related to a reference beam and a fluctuating 
signal is generated. Its frequency is proportional to the particles’ speed and thus, it is 
characteristic for UE and the ζ-potential. A scheme of the measurement principle is given on 
figure 3.3. 
 
 
Figure 3.3: Scheme of the ζ-potential measurement principle (from Malvern, Zetasizer nano users manual). 
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3.3 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) offers the possibility to detect surfaces of samples 
containing structures down to less than one nm in size. A cathode emits electrons that 
generate a high voltage beam. Since attracted by the anode, the electrons are accelerated in an 
electric field. Due to the very small wave length of such fast moving electrons, the resolution 
of electron microscopes is much higher than when using a light optical microscope. The 
resolution of the latter one is restricted by the shortest wave length of visible light. When 
applying the transmission mode, the electrons are detected after having passed through the 
sample. Therefore these samples need to be prepared as a very thin, electron semitransparent 
film. After magnification of the micrographs, the sample can be analyzed [75]. 
As dynamic and delicate structures do not support the drying or the staining and fixation steps 
that are necessary to prepare samples for conventional TEM, cryo-TEM may be used to 
analyze such formulations.  
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CHAPTER II  –  EXPERIMENTAL SECTION 
 
4 Materials and methods 
4.1 Materials 
Branched PEI (average MW: 25kDa), cholesterol and Tyrode’s salt were purchased from 
Sigma-Aldrich (Lyon, France). The composition of Tyrode’s solution is indicated in table 4.1. 
Sodium chloride solution for infusions (NaCl 0.9% w/v) was ordered from MacoPharma 
(Mouvaux, France) and Poloxamine 304 (Tetronic® 304) as well as poloxamer (Pluronic® 
PE6400) block copolymers were provided by BASF (Levallois, France). Randomly 
methylated β-cyclodextrin (Cavasol® W7 M) was obtained from Wacker Chemie 
(Burghausen, Germany), DC-cholesterol from Avanti polar lipids (Alabaster, USA) and 
chloroform from Carlo Erba Reagents (Val de Reuil, France). Water was purified using a 
Synergy system from Millipore (Molsheim, France).  
Table 4.1: Composition of Tyrode’s solution (1X). 
Salt Concentration [g/l] 
CaCl (anhydrous) 0.2 
MgCl2 (anhydrous) 0.1 
KCl 0.2 
NaCl 8.0 
NaH2PO4 (anhydrous) 0.05 
D-glucose 1.0 
NaHCO3 1.0 
 
 
4.2 Preparation and purification of pCMVβGal 
A 7.2kb reporter gene coding for bacterial β-galactosidase (pCMVβGal, Clontech, Saint 
Quentin Yvelines, France) was used as plasmidic reporter system (figure 4.1). It was 
introduced in JM109 E. coli via thermic shock treatment and amplified by that strain. 
Purification was performed with the plasmid purification kit NucleoBond® PC EF 10000 as 
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described by the manufacturer (Macherey-Nagel, Düren, Germany). The system employs an 
alkaline/sodium dodecyl sulfate (SDS) lysis buffer to prepare the bacterial cell pellet. Via this 
treatment, chromosomal and plasmid DNA are denatured. By addition of potassium acetate 
buffer, the lysate becomes neutral and chromosomal DNA as well as other cellular 
compounds precipitate. Plasmid DNA remains in solution. Purification was carried out by 
using a NucleoBond® column AX 10000. The column displays a silica-based anion-exchange 
resin that permits the negatively charged DNA phosphate backbone to bind specifically. 
Finally, the plasmid is eluted by washing the column with an appropriate buffer. Afterwards, 
plasmid DNA was precipitated by isopropanol, washed with ethanol and resuspended in 
water. The final DNA concentration was determined by UV spectrophotometry (NanoDrop® 
ND-1000 spectrophotometer) and its purity was checked through calculation of the 
DNA/protein and DNA/benzenes absorption ratios at the wave length of their maximum 
absorption (λmax (DNA) = 260nm, λmax (protein) = 280nm, λmax (benzenes) = 230nm). Each of 
three independent samples was measured three times. Furthermore, after digestion of the 
plasmid with 2 restriction enzymes, a gel electrophoresis was performed at 80mV. The gel 
was prepared in TAE buffer with 1% (w/v) of agarose (Eurogentech, Seraing, Belgium). 
EcoR1 (Invitrogen Life Technologies, Cergy Pontoise, France) was used to linearize the 
plasmid, and Not1 (New England Biolabs, Ipswich, USA) separated its insert from the 
backbone. As a marker, SmartLadder was applied (Eurogentec, Seraing, Belgium). 
 
 
 
Figure 4.1: Restriction map of pCMVβGal (adapted from Clontech, product information). 
EcoR  I 
23 
 
4.3 Preparation of the formulations 
Unless otherwise noted all experiments were performed at a DNA concentration of 0.13µg/µl. 
4.3.1 bPEI / DNA 
bPEI complexes were prepared at a final N/P ratio of 10. A bPEI stock solution of 60mg/ml 
was prepared in DNase and RNase free water. HCl was added until a pH value of 6.9 was 
reached. Before storage at -20°C, the solution was filtered through a 0.22µm PVDF 
membrane filter. Since 1µg of DNA contains 3nmoles of anionic phosphate, the volume 
needed to form the complexes was calculated as follows (equation 5).  
 
                
( of DNA 3) / ratio
of PEI stock solution to be used
of PEI
µg N Pµl b
mM b
⋅ ⋅
=                     (5) 
 
The bPEI molar concentration is expressed as concentration of monomer nitrogen residues. 
To form the complexes, a suitably diluted solution of bPEI was prepared in water and mixed 
equivolumetrically with 0.26µg/µl of the plasmids in water, NaCl 0.9% or Tyrode 2X. The 
samples were mixed by pipetting and by vortexing gently. Before being used, they were 
allowed to equilibrate at room temperature for at least 30 minutes.  
4.3.2 Poloxamine 304 / DNA 
Formulations containing poloxamine 304 all displayed a final concentration of 5% (w/v). As 
previously described by Pitard et al. [29], a 20% (w/v) stock solution of the block polymer 
was prepared in water and stored at 4°C. Before use, this solution was diluted with water to 
10% (w/v). Plasmid DNA was suitably diluted in purified water, 0.9% (w/v) NaCl or Tyrode 
2X. Afterwards, equal volumes of the DNA and Poloxamine 304 solutions were carefully 
mixed by pipetting and vortexed gently. Prior to their use, the complexes were given at least 
30 minutes of equilibration time at room temperature.  
4.3.3 PE6400 / DNA 
A stock solution of PE6400 at 2% (w/v) was prepared in water and kept at 4°C until used. The 
final concentration in the samples was set to 0.05% (w/v). Thus, the stock solution needed to 
be diluted by water to 0.1% before being equivolumetrically mixed with the DNA solution. 
The plasmid was prepared in ultra pure water, 0.9% (w/v) NaCl or 2X Tyrode’s solution. To 
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homogenize the samples, they were gently mixed during their preparation by pipetting and 
vortexed afterwards at relatively low speed. Before performing the measurements, the 
samples were allowed to equilibrate at room temperature for at least 30 minutes. 
4.3.4 rM-β-CD/DNA, rM-β-CD/cholesterol/DNA and rM-β-CD/DC-cholesterol/DNA 
If not otherwise stated, the samples contain 0.5% (w/v) of rM-β-CD and the lipid containing 
systems display a molar ratio of rM-β-CD/cholesterol or rM-β-CD/DC-cholesterol of 15:1.  
For rM-β-CD/DNA associations, equal volumes of an appropriately diluted solution of 
rM-β-CD in water, NaCl 0.9% or Tyrode 2X and a plasmid solution of 0.26µg/µl were gently 
pipeted and vortexed. The samples were investigated after 30min of equilibration. 
The cholesterol or DC-cholesterol containing formulations were prepared as follows: the first 
step consisted in complexation of the lipids with rM-β-CD. We applied two methods, named 
#1 and #2, respectively. When using #1, calculated amounts of cholesterol or DC-cholesterol 
were weighed into a volumetric flask. This one was filled till the gage mark with a solution of 
rM-β-CD at the desired concentration, prepared by simply dissolving solid rM-β-CD in water. 
The suspensions were allowed to equilibrate at 25°C during 5 days under magnetic stirring. 
Christian et al. suggested a different method (#2) to obtain such complexes [64] which was 
adapted as follows: a cholesterol or DC-cholesterol stock solution of 10µg/µl was prepared in 
chloroform. A suitable volume was taken and chloroform was evaporated at 80rpm within 1.5 
hours. (rotavapor R-124, Büchi laboratory equipment, Flawil, Switzerland). Thereby a film of 
the sterols was formed at the walls of the tube. A solution of rM-β-CD was prepared as 
described for #1. An appropriate volume of rM-β-CD solution was added to the tubes to 
redissolve the film of cholesterol or DC-cholesterol. The dried cholesterol was brought off the 
borders by vortexing the solutions during 30s and by 3min of sonication in a bath sonicator. 
The tubes were stored overnight in an incubation chamber at 37°C under agitation. DNA 
solutions of 0.26µg/µl were prepared in water or Tyrode 2X and added to equal volumes of 
rM-β-CD/cholesterol or rM-β-CD/DC-cholesterol. The samples were mixed via gently 
pipetting and vortexing and, thereafter, they were allowed to equilibrate for at least 30min. 
As indicated later, the formulations were filtered through several filter types, centrifuged at 
different speed, varied in initial or final rM-β-CD concentration or adapted in 
rM-β-CD/cholesterol or rM-β-CD/DC-cholesterol ratios. 
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4.4 Dynamic light scattering (DLS) 
The distribution of the complexes’ hydrodynamic size was obtained by dynamic light 
scattering measurement. For our investigations, a Zetasizer Nano ZS (Malvern, 
Worcestershire, England) was used. The emitted laser light features a wave length of 633nm 
and the scattered information is detected upon a 173° angle via backscatter detection. For 
each formulation, the results of at least three separately produced samples, whereof each was 
measured three times at 25°C, were averaged and expressed as mean ± standard deviation. To 
compare the mean hydrodynamic size values of different formulations, Student’s t-test was 
applied, setting the level of significance to p < 0.05.  
For rM-β-CD/DC-cholesterol/DNA associations, stability of the size profile curves obtained 
from the formulations was further investigated depending on temperature. Therefore, the 
apparatus was set to perform measurements from 37°C down to 4°C in steps of 3K.  
4.5 Zeta potential (ζ-potential) 
For our measurements the Zetasizer Nano ZS (Malvern, Worcestershire, England) was used. 
The apparatus processed the information according to the Smoluchowski approximation. 
Again, the values were obtained form three samples, all measured three times at 25°C. For 
each system, the results were averaged and expressed as mean ± standard deviation. Student’s 
t-test was applied to determine, whether two mean values were significantly different from 
each other or not (p < 0.05). 
4.6 Cryo-transmission electron microscopy (cryo-TEM) 
To obtain a very thin sample film, 5µl of the aqueous solutions are applied to a lacey 
formvar/carbon copper grid (Ted Pella, USA), that is clamped into a specimen holder. After 
blotting excess amounts of the formulations, the grid is plunged into liquid ethane, whereas 
the film vitrifies instantaneously without crystallization. During all the following operations 
and during the measurement, the specimen has to be kept at liquid nitrogen temperature to 
avoid thawing. Subsequently, the sample is placed into a cooled transfer unit, inserted into the 
microscope and examined in transmission mode. 
For our investigations we used an EM 912 Omega microscope (Carl Zeiss NTS, Göttingen, 
Germany), operating at 120kV.  
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5 Results 
5.1 DNA 
5.1.1 Verification of the plasmid by gel electrophoresis 
After purification of plasmid DNA from E. coli, each preparation was submitted to the 
verification of the plasmid obtained, as well as to the evaluation of its concentration and 
purity. Verification of the plasmid was performed through gel electrophoresis on intact and 
enzymatically digested DNA samples. By the help of a molecular weight marker, the quantity 
of kilo base pairs, building up the investigated plasmid, is assessable. As shown on figure 5.1, 
intact pCMVβGal (Pintact) migrates farther than expected for a 7.2kb plasmid which results 
from its supercoiled form. As expected, the linearized sample (PEcoR1) has been found between 
the 6 and 8kb bands of the marker, indicating 7.2kb. As pCMVβGal exhibits two restriction 
sites for Not1, after digestion of the plasmid by that enzyme (PNot1), two bands corresponding 
to two DNA fragments were obtained. All those findings confirm the identity of the 
pCMVβGal reporter gene. 
 
 
Figure 5.1: Photograph of a 1% agarose gel of pCMVβGal before (Pintact) and after digestion by EcoR1 (PEcoR1) 
and Not1 (PNot1) restriction enzymes to check identity and purity of the plasmid. M = molecular weight marker. 
 
5.1.2 Evaluation of DNA concentration and purity by UV spectrophotometry 
After plasmid purification, we reached final DNA concentrations of 4.3 to 7.8µg/µl. 
Moreover, purity of the samples was confirmed through the absorption ratios of 
260nm/280nm and 260nm/230nm. DNA was considered pure when the ratios ranged between 
1.8-2.0 and 2.2-2.4, respectively. All our samples correspond to that criterion. 
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5.1.3 Size of DNA in different dispersants 
Prior to the evaluation of the various formulations, naked DNA was investigated through DLS 
measurements in water, 0.45% (w/v) of NaCl and Tyrode’s solution. We worked at a plasmid 
concentration of 0.13µg/µl. In water and in NaCl 0.45%, laser power was set to 100%, whilst 
30 or 100% were applied in Tyrode. In both ion-containing dispersants, the count rate was 
increased by 3 to 4-fold with reference to water. Moreover, a non-consistent and unstable 
profile was obtained in water. Several peaks were observed, whose positions displayed great 
inter- and intraindividual variations. Thus, no mean sizes could be specified. In NaCl 0.45% 
as well as in Tyrode’s solution, more consistent findings displaying two major peaks resulted 
from the measurements (see figure 5.2). When looking at the size distribution by intensity, the 
main population showed a mean hydrodynamic diameter of 134nm for both dispersants. 
Within some measurements, a further peak was detected at about 20nm. Since the PDI 
decreased from water over NaCl 0.45% to Tyrode, higher homogeneity for DNA in salt 
containing dispersant was indicated. For the summarized results see table 5.1. 
Table 5.1: Results obtained by DLS measurements for naked DNA in different dispersants. 
 Dispersant pH Peak I [nm] Peak II [nm] PDI 
DNA 
Water 5.8 -  * -  * 0.53 ± 0.19 
NaCl 0.45% 6.6 134 ± 13 21.0 ±6.9 0.43 ± 0.04 
Tyrode 8.1 134 ± 6 18.7 ± 2.2 0.35 ± 0.11 
* As several unstable peaks were obtained, no mean value may be indicated. 
 
 
Figure 5.2: Size distribution profile by intensity for DNA at a concentration of 0.13µg/µl in NaCl 0.45% and 
Tyrode’s solution. 
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5.1.4 ζ-potential of DNA in different dispersants 
No significant difference could be observed between the ζ-potential measurements obtained 
for pDNA in water or in Tyrode’s solution (see table 5.2). However, for NaCl 0.45% an even 
more negative value was obtained. When looking at the phase plot profile, data quality 
resembled each other for all the three dispersants. 
Table 5.2: ζ-potential for naked DNA in different dispersants. 
 Dispersant ζ-potential [mV] 
DNA 
Water -25.6 ± 4.2 
NaCl 0.45% -39.5 ± 2.9 
Tyrode -27.3 ± 3.8 
 
 
5.2 bPEI/DNA 
5.2.1 Size of bPEI and bPEI/DNA complexes in different dispersants 
To serve as a reference, non-complexed bPEI was measured at the same concentration used to 
form bPEI/DNA complexes at an N/P ratio of 10. For such dilution, laser power was 
automatically set to maximum transmission. With reference to water, the count rate was 
increased by 2-fold in Tyrode’s solution. After preparation in that dispersant, the main peak of 
bPEI itself showed a slightly, but non-significantly lower average size when compared to the 
same peak obtained in water (see table 5.3). Although in water some specimen showed a 
second population of weaker intensity, the PDI values were found to be similar for both 
media. All those findings indicate no important size profile changes for bPEI alone depending 
on the dispersant. Since for water and Tyrode’s solution almost the same size intensity 
profiles were obtained, similar results are expected for NaCl 0.45% and thus, no examinations 
were carried out for that latter dispersant.  
In water, DNA that was complexed by bPEI exists as particles of 86.7 ± 2.6nm in 
hydrodynamic diameter (see table 5.3), displaying a well reproducible and fairly narrow peak. 
When adding bPEI solution to DNA prepared in NaCl 0.9% or in Tyrode 2X, respectively, a 
macroscopically visible precipitation occurred. The aggregates sank to the bottom of the 
cuvette and were therefore not detected. In water, such precipitation did not occur. To perform 
the measurements, the apparatus automatically set laser power to values from 0.3 to 1%, 
indicating much more or larger detectable material in the solutions.  
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When prepared in NaCl 0.45%, the peak position was shifted to a higher mean value and in 
Tyrode, the increase of the hydrodynamic diameter was even more pronounced. Furthermore, 
in the latter dispersant the mean hydrodynamic diameter augmented with time. This led to 
increasing values for the three samples measured one after each other and thus, a high 
standard deviation resulted. For bPEI/DNA complexes prepared in NaCl 0.45% or Tyrode, 
measurements were carried out on the supernatant and macroscopic aggregates are thus not 
taken into account. For a comparative illustration of the complexes’ hydrodynamic diameters 
in dependence on the dispersant and a representative correlation graph, similar for water, 
NaCl 0.45% and Tyrode, see figure 5.3.  
In water, increasing the plasmid concentration of the bPEI/DNA complexes up to 0.8mg/ml 
was possible without any precipitation. Compared to the complexes at a DNA concentration 
of 0.13mg/ml, the mean hydrodynamic diameter was significantly augmented to 231 ± 14.0nm 
and displayed an increased PDI value of 0.37 ± 0.02. 
Table 5.3: Summary of the results obtained by DLS for PEI and PEI/DNA complexes in different dispersants. 
  Dispersant pH Peak I [nm] Peak II [nm] PDI 
PEI alone 
Water 5.3 20.3 ± 2.1 2.8 ± 1.7 0.26 ± 0.13 
Tyrode 7.7 18.5 ± 3.2 - 0.29 ± 0.07 
PEI/DNA 
Water 5.5 86.7 ± 2.6 - 0.20 ± 0.01 
NaCl 0.45% 6.5 186 ± 23.3 - 0.30 ± 0.03 
Tyrode 8.1 380 ± 144 - 0.14 ± 0.10 
 
5.2.2 ζ-potential of bPEI and bPEI/DNA complexes in different dispersants 
The ζ-potential of bPEI in various media is shown in table 5.4. The values obtained in NaCl 
0.45% and Tyrode’s solution do not significantly differ from each other, whereas they were 
importantly decreased when comparing to water. In this latter dispersant, the samples 
exhibited the best, but still neither very stable nor homogenous data quality.  
After complexation of bPEI and DNA in water, we obtained a narrow, precise and 
reproducible peak. The ζ-potential decreased when increasing the salt concentrations (see 
table 5.4). Complexes prepared in Tyrode displayed values that were similar to the ones 
obtained for bPEI alone in the same medium. As seen on figure 5.4, the peak width increased 
in the following order: water (4.3 ± 0.4mV) < NaCl 0.45% (11.7 ± 0.72mV) < Tyrode (12.8 ± 
2.1mV). In general, the phase plot quality was better than for non-complexed bPEI. Again, 
data were the most homogenous in water, followed by NaCl 0.45% and Tyrode. 
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Figure 5.3: Hydrodynamic diameter of bPEI/DNA complexes prepared in different dispersants, measured 
through DLS: a) Size distribution by intensity, b) Illustration of mean hydrodynamic diameter and standard 
deviation bars. c) Representative correlation graph for bPEI/DNA complexes, similar for all the three 
dispersants.  
 
Table 5.4: ζ-potential for PEI and PEI/DNA complexes in different dispersants. 
  Dispersant ζ-potential [mV] 
PEI alone 
Water 31.4 ± 5.7 
NaCl 0.45% 19.3 ± 6.2 
Tyrode 21.9 ± 7.6 
PEI/DNA 
Water 47.1 ±  1.2 
NaCl 0.45% 31.7 ±  1.1 
Tyrode 20.9 ±  1.9 
 
a 
Cb
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Figure 5.4: ζ-potential distribution of bPEI / DNA complexes in water, NaCl 0.45% and Tyrode’s solution. 
 
5.2.3 Size and shape investigations of bPEI/DNA complexes in water by cryo-TEM 
To assess the shape of bPEI/DNA complexes formed in water, cryo-TEM experiments were 
carried out. Relatively small complexes of less than 100nm were detected. The condensates 
exhibited discrete dense structures (figure 5.5a) as well as folded loops of DNA (figure 5.5b).  
 
 a        b 
Figure 5.5: cryo-TEM micrographs of bPEI/DNA complexes in water: a) discrete dense DNA condensates and  
b) folded DNA loop. 
 
5.3 Poloxamine 304/DNA 
5.3.1 Size of poloxamine 304 and its formulations in different dispersants 
Poloxamine 304 was investigated at 5% (w/v) by DLS measurements in water, NaCl 0.45% 
and Tyrode. In water and NaCl 0.45%, two populations of different sizes were detected (see 
table 5.5 and figure 5.6a). When poloxamine 304 was added to Tyrode’s solution, the samples 
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became opalescent. Laser power was diminished from 100% in water and NaCl 0.45% to 1% 
in Tyrode. When looking at the correlation curves (see figure 5.6c), it is obvious that even 
larger populations, not represented in the distribution by intensity, were present in the 
samples. 
We obtained two similar peaks for poloxamine 304/DNA systems in water as well as in NaCl 
0.45% (see table 5.5 and figure 5.6b). The correlation data support the presence of two 
populations (see figure 5.6d). The count rates for both dispersants were similar but elevated 
when compared to 5% of poloxamine 304 alone. In water, it was even augmented by 3.5-fold 
with reference to DNA itself, whereas the value did not change for NaCl 0.45%. For both 
media, the association of DNA with poloxamine 304 resulted in an increased PDI when 
compared to the polymer alone.  
When preparing DNA in 2X Tyrode’s solution and mixing it with a poloxamine 304 solution 
at 10% in water, no precipitation occurred. Compared to the PDI value for poloxamine 304 
alone, polydispersity decreased after DNA addition. A single, relatively reproducible peak 
was observed, displaying a larger mean hydrodynamic diameter than obtained for the 
formulations prepared in water and NaCl 0.45%. Within two of the measurements of one 
sample, a second peak appeared at about 90nm. Laser power was attenuated from 100% (for 
the complexes in water and NaCl 0.45%) to 0.3% of the maximum in Tyrode. 
Table 5.5: Summary of the results obtained by DLS measurements for poloxamine 304 and poloxamine 
304/DNA associations in different dispersants. 
 
  Dispersant pH Peak I [nm] Peak II [nm] PDI 
Poloxamine 
304 
Water 9.7 2.42 ± 0.08 136 ± 31 0.25 ± 0.08 
NaCl 0.45% 9.5 2.54 ± 0.13 140 ± 41 0.27 ± 0.04 
Tyrode 9.3 1378 ± 382 - 0.48 ± 0.14 
Poloxamine 
304 / DNA 
Water 9.6 2.44 ± 0.03 163 ±   6 0.80 ± 0.03 
NaCl 0.45% 9.7 2.39 ± 0.04 136 ± 25 0.75 ± 0.27 
Tyrode 9.4 553 ± 14 - 0.26 ± 0.01 
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Figure 5.6: Size distribution by intensity of a) poloxamine 304 (5%) and b) poloxamine 304/DNA associations, 
prepared in different dispersants, measured through DLS. Correlation graphs for c) poloxamine 304 and d) 
poloxamine 304/DNA associations for all the three dispersants.  
a 
b 
c d 
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When augmenting the plasmid concentration in poloxamine 304/plasmid associations in 
Tyrode, the hydrodynamic diameters obtained from DLS measurements shifted to higher 
values (see figure 5.7). A similar tendency occurred for a lower DNA content in the 
formulations, indicating a minimal hydrodynamic diameter for poloxamine 304/DNA 
associations prepared with 0.13µg/µl of plasmid.  
For 0.5 and 0.8µg/µl of DNA, a second peak which was not very stable and homogenous 
appeared at a mean average size of 69.4 ± 38.8nm and 93.3 ± 35.2nm, respectively.  
 
 
Figure 5.7: Hydrodynamic diameter of poloxamine 304/DNA associations in Tyrode at different DNA 
concentrations (0.05µg/µl; 0.13µg/µl; 0.5µg/µl; 0.8µg/µl). 
5.3.2 ζ-potential of poloxamine 304 and its formulations in different dispersants 
In water, the count rate was too low to measure the ζ-potential of poloxamine 304 alone at 
5%. Thus, only data in NaCl 0.45% and Tyrode’s solution are available and presented on 
table 5.6. For both dispersants, the phase plot data displayed a low signal to noise ratio. 
Associations of poloxamine 304 and DNA prepared in water displayed a clearly negative 
ζ-potential value which increased for formulations formed in NaCl 0.45%. In contrast, when 
using Tyrode’s solution as dispersant, the ζ- potential was found to decrease again. The 
ζ-potential of the systems in Tyrode was significantly lower than the one measured for 
poloxamine 304 alone. For all the three dispersants we obtained neither narrow nor 
homogenous and stable peaks. Several times, multiple peak profiles were obtained. In general, 
the phase plot quality was increased when compared to poloxamine 304 alone in Tyrode, but 
it was still not satisfying. Thereby, in water the data was the most homogenous. 
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Table 5.6: ζ-potential for poloxamine 304 and poloxamine 304/DNA associations in different dispersants. 
 Dispersant ζ-potential [mV] 
Poloxamine 304 alone 
Water - 
NaCl 0.45% -4.6 ± 2.8 
Tyrode 1.3 ± 1.1 
Poloxamine 304 / DNA 
Water -23.4 ± 2.7 
NaCl 0.45% -11.8 ± 2.2 
Tyrode -20.9 ± 1.1 
 
5.3.3 Size and shape investigations of poloxamine 304/DNA associations in Tyrode by 
cryo-TEM 
To investigate the shape of poloxamine 304/DNA associations formed in Tyrode’s solution, 
cryo-TEM experiments were carried out. Two different particle populations, displaying 
various shapes, were found. Spherical condensates of less than 100nm with plane surfaces, are 
shown on figure 5.8a. Figure 5.8b illustrates a single sphere with a grained or a kind of hairy 
exterior. 
 
 a        b 
Figure 5.8: cryo-TEM micrographs of Poloxamine 304/DNA associations in Tyrode’s solution: a) Spherical 
condensates with a plane surface. b) Single sphere with grained or hairy exterior. 
 
5.4 PE6400/DNA 
5.4.1 Size of PE6400 and PE6400/DNA formulations in different dispersants 
As a reference, a solution of 0.05% of the poloxamer PE6400 was investigated by DLS 
measurements in water and Tyrode’s solution. Laser power was automatically set to 
maximum transmission, when measuring such a strongly diluted sample, but still the count 
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rate was almost at the lower limit for both dispersants. Similar size distribution profiles with 
two peaks were obtained for water as well as for Tyrode (figure 5.9a). The first peak of 
smaller size displayed close but significantly different values for water and Tyrode, whereas a 
second one displayed a larger hydrodynamic diameter without any significant differences 
depending on the dispersant. The PDI values were found to be similar as well. Correlation 
data for both dispersants was of very poor quality and hardly analyzable. Since for water and 
Tyrode’s solution almost the same size intensity profiles were obtained, comparable results 
are also expected in NaCl 0.45%. The results are summarized in table 5.7.  
For the assessment of the associations between plasmid and copolymer, the laser beam was 
set to maximum power again. In comparison to PE6400 alone, all samples displayed a higher 
mean count rate that was similar to the one obtained for DNA alone in the same dispersants. 
The evaluation of PE6400/DNA led to the following results: for all the three dispersants, the 
data resemble to the ones obtained for DNA alone in water. In water, several times a peak of 
about 4.9nm was detected that did not appear when measuring DNA alone. It might somehow 
correspond to the peak at 3.1nm obtained by the investigations of PE6400 alone. For a 
summary of the results see table 5.7; size distribution graphs for the formulations prepared in 
the salt containing dispersants are illustrated in figure 5.9b.  
Table 5.7: Summary of the results obtained by DLS measurements for PE6400 and PE6400/DNA complexes in 
different dispersants. 
  Dispersant pH Peak I [nm] Peak II [nm] PDI 
PE6400 
Water 5.8 3.1 ± 0.6 211 ± 30 0.72 ± 0.19 
Tyrode 8.1 3.7 ± 0.6 231 ± 81 0.67 ± 0.17 
PE6400/DNA 
Water 5.8 4.9 ± 1.1      - * 0.62 ± 0.15 
NaCl 0.45% 6.7 16.8 ± 2.1 118 ±  9 0.33 ± 0.06 
Tyrode 8.4 22.4 ± 10.2  146 ± 15 0.33 ± 0.04 
* As several unstable peaks were obtained, no mean value may be indicated. 
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Figure 5.9: Size distribution by intensity of a) PE6400 (0.05%) prepared in water and Tyrode’s solution and b) 
PE6400/DNA systems in NaCl 0.45% or Tyrode, measured through DLS.  
 
For PE6400/DNA formulations in Tyrode’s solution, no differences were observed when the 
DNA concentration was increased up to 0.8µg/µl. Although the attenuation of the laser beam 
was raised, representing the augmentation of DNA concentration, the DLS profile still 
resembles to DNA alone in Tyrode (data not shown). 
5.4.2 ζ-potential of PE6400 and its formulations in different dispersants 
As PE6400 is a non-ionic block copolymer, no ζ-potential measurements could be achieved. 
No results were obtained either, when trying to determine the ζ-potential of PE6400/DNA 
associations in water. Thus, only data for the complexes prepared in NaCl 0.45% and in 
Tyrode’s solution are available. For these two dispersants, 100% of the laser beam was used. 
b 
a 
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The values obviously resemble the data obtained from DNA alone, whereas in Tyrode a less 
negative potential was detected. The zeta potential was determined as displayed on table 5.8.  
Table 5.8: ζ-potential for PE6400/DNA systems in different dispersants. 
 Dispersant ζ-potential [mV] 
PE6400/DNA 
Water - 
NaCl 0.45% -31.8 ± 2.8 
Tyrode -24.5 ± 4.1 
 
5.4.4 Size and shape investigations of PE6400/DNA formulations in Tyrode by cryo-TEM 
PE6400/DNA associations were prepared in Tyrode’s solution to examine their shape by 
cryo-TEM investigations. Spherical structures were obtained, as shown in figure 5.10. The 
vesicles display varying sizes, ranging from about 10 to 50 nm. 
 
 
Figure 5.10: cryo-TEM investigation of PE6400/DNA formulations in Tyrode’s solution: arrangement of 
spherical formations of different size, lamellar structures at the bottom image border.  
 
 
5.5 rM-β-CD/DNA, rM-β-CD/cholesterol/DNA and rM-β-CD/DC-cholesterol/DNA 
To examine the rM-β-CD containing formulations’ effects for muscular tissue in vivo, a 
toxicological study preceded the present work. rM-β-CD solutions of different concentrations 
were injected into tibialis anterior and quadriceps muscles of Syrian hamsters. Seven days 
later the animals were sacrificed with an overdose of anesthetics and the muscles were 
removed and analyzed. As expected, toxicity increased with CD concentration, displaying 
severe inflammations and necrosis from 2 to 10% (w/v) of rM-β-CD. Since for 1%, but not 
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for 0.5%, a local inflammation at the injection site was still observed, we chose to principally 
examine the latter concentration in our formulations.  
5.5.1 Size investigations of rM-β-CD, rM-β-CD/cholesterol and rM-β-CD/DC-cholesterol 
before and after addition of DNA 
Table 5.9: Summary of the results obtained by DLS for rM-β-CD, rM-β-CD/cholesterol, rM-β-CD/DC-
cholesterol and their associations with DNA in water and Tyrode. 
 
 
Dispersant pH 
Peak I  
[nm] 
Peak II 
[nm] 
Peak III 
[nm] 
PDI 
rM-β-CD 
Water 6.3 1.76 ± 0.08 - 233 ± 76 0.43 ± 0.10 
Tyrode 8.2 1.95 ± 0.12 - 280 ± 66 0.37 ± 0.10 
rM-β-CD / 
cholesterol * 
Water 6.5 1.83 ± 0.03 56.0 ± 10.0 280 ± 37 0.49 ± 0.10 
Tyrode 8.2 2.21 ± 0.05 - 431 ± 57 0.47 ± 0.08 
rM-β-CD / 
DC-cholesterol 
Water 6.5 1.89 ± 0.11 - 287 ± 80 0.39 ± 0.15 
Tyrode 8.1 2.16 ± 0.13 - 330 ± 54 0.34 ± 0.07 
rM-β-CD / DNA 
water § 6.5 1.82 ± 0.10 - - 0.39 ± 0.22 
Tyrode 8.1 - 25.1 ± 3.1 141 ± 13 0.37 ± 0.09 
rM-β-CD / 
cholesterol / DNA 
Water 6.8 1.93 ± 0.17 29.4 ± 9.2 166 ± 17 0.53 ± 0.21 
Tyrode 8.2 - 22.8 ± 7.2 127 ± 16 0.45 ± 0.07 
rM-β-CD / 
DC-cholesterol / DNA 
Water 6.7 2.07 ± 0.17 22.9 ± 8.6 174 ± 27 0.61 ± 0.18 
Tyrode 8.0 - 20.2 ± 6.2 163 ± 34 0.48 ± 0.02 
If not otherwise noted: [rM-β-CD] = 0.5% (w/v), rM-β-CD/DC-cholesterol = 15:1, rM-β-CD/DC-cholesterol = 
15:1, [DNA] = 0.13 µg/µl. * [rM-β-CD] = 1%.  § Apart from the monomeres’ peak, profile not stable enough to 
indicate mean diameters. 
 
rM-β-CD itself was examined by DLS measurement at 0.5% (w/v) in water as well as in 
Tyrode’s solution. Solutions of rM-β-CD at 1% (w/v) were diluted to 0.5% to guarantee the 
same conditions of preparation like later applied for CD association to the plasmid. The size 
profiles obtained in the two dispersants resembled each other and thus, investigations in NaCl 
0.45% were not carried out. For both, maximal laser power was applied automatically, but the 
mean count rate remained at the lower limit. The most intense peak (peak I) represented in 
table 5.9 was stable within all samples. In Tyrode, it displayed a significantly larger 
hydrodynamic diameter than in water. A second peak was also detected (see table 5.9). The 
hydrodynamic diameters obtained in the two dispersants were not significantly different and 
the PDI values resembled to each other, as well. For the size distribution by intensity 
depending on the dispersant, see figure 5.11.  
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Within the majority of the samples, a further, low intense population of large aggregates 
appeared at 4500 to 5500nm, whereas it needs to be kept in mind that only particles up to 
6000nm may be detected by the apparatus. We tried to eliminate the large structures by 
filtration through 0.80µm and 0.22µm polyvinylidene fluoride (PVDF) filters as well as 
through 0.45µm cellulose acetate (CA) membranes. We did neither succeed in removing these 
large aggregates from the solutions of rM-β-CD in water, nor in Tyrode. For PVDF 
membranes of 0.22µm, a decrease in the intensity of the smaller aggregates’ peak and a 
significantly increased hydrodynamic diameter of the monomers occurred for both 
dispersants. Furthermore, the hydrodynamic diameter of the monomers decreased when using 
CA membranes of 0.45µm. 10min of centrifugation at up to 6000rpm, was not sufficient to 
achieve a separation of the large structures either.  
When preparing a rM-β-CD solution at 1% (w/v), the size distribution profiles did not 
significantly change (data not shown).  
 
 
Figure 5.11: Size distribution by intensity of rM-β-CD (0.5%) prepared in water and Tyrode’s solution, 
investigated by DLS measurements.  
 
The complexes between rM-β-CD and cholesterol were prepared by method #2 ([rM-β-CD] = 
1%; CD/cholesterol molar ratio = 15:1) and afterwards investigated by DLS. In water, the 
apparatus detected three populations, as shown on table 5.9. Thereof, the one representing the 
CD monomers was significantly increased in its hydrodynamic diameter when comparing to 
rM-β-CD alone. Again, µm-sized aggregates were present. When performing the 
measurement in Tyrode’s solution, we observed only two peaks. Both showed significantly 
larger hydrodynamic diameters than obtained for the same specimens prepared in water and 
than rM-β-CD itself in Tyrode’s solution. For both dispersants, again full laser power was 
applied, but as expected, the mean count rate was higher than for 0.5% of rM-β-CD. As the 
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size distribution profiles strongly resemble the ones obtained for rM-β-CD alone (see figure 
5.11), the curves are not shown. 
Afterwards, the solutions at 1% rM-β-CD were half diluted with water or Tyrode. Thereby, 
the samples turned opalescent, suggesting a precipitation of cholesterol that was confirmed by 
the results of DLS investigations. The PDI increased from 0.49 ± 0.10 to 0.99 ± 0.03 in water 
and from 0.47 ± 0.12 to 0.96 ± 0.08 in Tyrode’s solution. When looking at the correlation 
graph (see figure 5.12), the presence of large particles is obvious. The noise after 10000µs 
may be improved by increasing the number of measurements or the run time. 
 
 
Figure 5.12: Correlations graphs of rM-β-CD/cholesterol ([rM-β-CD] = 0.5%, rM-β-CD/cholesterol = 15:1) 
associations in water and Tyrode a) before and b) after dilution from [rM-β-CD] = 1% by water or Tyrode. 
 
By direct preparation of rM-β-CD/cholesterol (15:1) complexes at 0.5% of rM-β-CD, a 
precipitation may be prevented. We obtained results comparable to the ones that were 
previously described for the non-diluted samples of rM-β-CD(1%)/cholesterol. Complexes 
containing various rM-β-CD concentrations (0.1%, 2% and 5%) were also tested, whereof all 
showed the same behavior like the solutions of 0.5% and 1% of rM-β-CD. It was examined, 
that the monomer’s hydrodynamic diameter shifted to higher values with increasing rM-β-CD 
concentration. 
 
Complexes of rM-β-CD with DC-cholesterol were investigated as well. Automatically, full 
laser power was set. The size distribution profiles for both dispersants resemble each other, 
showing two main peaks and a low intense third one of µm-sized aggregates. For both 
dispersants, the hydrodynamic diameter of the monomers is increased when comparing to the 
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value obtained for rM-β-CD alone. Furthermore, in Tyrode that diameter is significantly 
larger than in water. The PDI values hardly differ from each other. Again, the size distribution 
curves are not shown, since they resemble the ones of rM-β-CD alone in water and Tyrode 
(see figure 5.11).  
Like previously demonstrated for rM-β-CD, it was not possible to separate the µm-sized 
structures present in the samples by filtration. We just obtained a diminishment in the 
intensity of the peak displaying the smaller aggregates and a hydrodynamic diameter of the 
monomer’s peak that was shifted to higher values.  
Neither variations of the rM-β-CD concentration from 1% to 0.5% nor changes in the 
rM-β-CD/DC-cholesterol ratio between 15:1 and 60:1 strongly influenced the size distribution 
profile examined by DLS. We further modified the preparation method from #1 to #2 and 
again, no significant changes were observed. In contrast to the complexes prepared with non-
charged cholesterol, even dilution down to 1/10 (from 5% to 0.5% of rM-β-CD) was possible 
without any precipitation. A representative example is shown on table 5.9. 
 
Formulations of rM-β-CD and DNA displayed size distribution profiles that resembled the 
ones obtained for DNA alone in water as well as in Tyrode. In water, the only stable peak was 
recorded from the rM-β-CD monomer that was less intense than without the presence of DNA 
in the samples. Like for non-complexed DNA in water no further mean sizes may be 
indicated. When applying Tyrode as dispersant, the peak that symbolizes monomeric 
rM-β-CD was no more present in the solutions. For both dispersants, the PDI values were of 
the same order and again, a low amount of µm-sized particles was detected within the 
samples. The hydrodynamic diameters of the formulations are displayed on table 5.9. 
Furthermore, the stability of the complexes was assessed in a range from 37°C down to 4°C. 
Thereby, the obtained size distribution profiles did not change importantly. 
rM-β-CD, cholesterol and DNA were also associated in water and Tyrode. Thereby, the 
method of preparation (#1 or #2) did not influence the profiles obtained. All the displayed 
results were obtained from samples prepared by the latter method.  
Although precipitation occurred when diluting the complexes without DNA from 1% of 
rM-β-CD to 0.5%, such a phenomenon did not happen in the presence of plasmids. In water, 
the profile was stable enough to indicate three peaks, as displayed on table 5.9. They were 
accompanied by few µm-sized aggregates. Count rate and attenuation index were alike 
previously described for rM-β-CD/DNA. Again, the peak for monomeric rM-β-CD was no 
more present for samples prepared in Tyrode’s solution and thus, apart from the µm-sized 
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structures, two populations remained. The PDI was slightly decreased and displayed a lower 
standard deviation when using Tyrode as dispersant. For the size distribution profile by 
intensity, see figure 5.13. 
 
 
Figure 5.13: Size distribution by intensity of rM-β-CD/cholesterol/DNA ([rM-β-CD] = 0.5%, 
rM-β-CD/cholesterol = 15:1, [DNA] = 0.13µg/µl) prepared in water and Tyrode’s solution investigated by DLS.  
 
Finally, rM-β-CD, DC-cholesterol and DNA were associated and examined ([rM-β-CD] = 
0.5%, rM-β-CD/DC-cholesterol = 15:1). As presented on table 5.9, three populations were 
detected in water. The peak of the rM-β-CD monomers was less intense but the hydrodynamic 
diameter was increased compared to the solutions without plasmids. As for the same 
complexes prepared with cholesterol, the size distribution profile generally appeared more 
stable than the one of uncomplexed DNA or rM-β-CD/DNA in water. Once again, monomeric 
rM-β-CD was no more found in the samples when using Tyrode as dispersant. Compared to 
water, the PDI value was decreased in Tyrode’s solution.  
In both dispersants, the main peaks were accompanied by µm-sized structures. As shown on 
figure 5.14, the size distribution profile is similar to the one obtained from 
rM-β-CD/cholesterol/DNA. 
 
As a final aspect, preparing rM-β-CD/cholesterol/DNA and rM-β-CD/DC-cholesterol/DNA 
complexes in Tyrode at DNA concentration up to 0.8µg/µl, did not significantly change the 
results. The size distribution profile obtained was similar to the one recorded from the 
samples at low plasmid concentration. Since more material was present in the samples, laser 
power was more attenuated (10%). The DLS profile resembled to naked DNA in Tyrode. 
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Figure 5.14: Size distribution by intensity of rM-β-CD/DC-cholesterol/DNA ([rM-β-CD] = 0.5%, rM-β-CD:     
DC-cholesterol = 15:1, [DNA] = 0.13µg/µl) prepared in water and Tyrode, investigated by DLS measurements.  
 
5.5.2 ζ-potential measurement of rM-β-CD/cholesterol/DNA and rM-β-CD/ 
DC-cholesterol/DNA complexes 
Table 5.10: Summary of the results obtained by ζ-potential measurements for rM-β-CD, rM-β-CD/cholesterol, 
rM-β-CD/DC-cholesterol and their associations with DNA in water and Tyrode. 
 Dispersant ζ-potential [mV] 
rM-β-CD 
Water        -  * 
Tyrode        -  * 
rM-β-CD / cholesterol 
Water -23.1 ± 5.7 
Tyrode   -9.8 ± 4.4 
rM-β-CD / DC-cholesterol 
Water        -  * 
Tyrode        -  * 
rM-β-CD / DNA 
Water        -  * 
Tyrode        -  * 
rM-β-CD / cholesterol / DNA 
Water        -  * 
Tyrode -19.9 ± 5.7 
rM-β-CD / DC-cholesterol / 
DNA 
Water -48.9 ± 2.6 
Tyrode -27.0 ± 2.6 
If not otherwise noted: [rM-β-CD] = 0.5% (w/v), rM-β-CD/cholesterol = 15:1, rM-β-CD/DC-cholesterol = 15:1, 
[DNA] = 0.13 µg/µl.   * Count rate too low to perform the measurements. 
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No ζ-potential could be recorded with rM-β-CD or rM-β-CD/DC-cholesterol complexes, 
neither in water nor in Tyrode, but the apparatus succeeded in calculating a ζ-potential for 
rM-β-CD/cholesterol. As displayed on table 5.10, a strongly negative value was obtained in 
water, whereas for Tyrode’s solution, the ζ-potential was found to be less negative.  
When having tried to evaluate the association between rM-β-CD and DNA in both dispersants 
and between rM-β-CD, cholesterol and DNA in water, the count rate was not sufficient to 
perform the measurements. Thus, for the latter formulation only values for Tyrode’s solution 
are available (see table 5.10). The ζ-potential displayed by the samples is increased when 
compared to naked DNA, but still negative.  
Formulations associating rM-β-CD, DNA and single positively charged DC-cholesterol were 
found to exhibit a ζ-potential that was as negative as -50mV in water. The intensity of the 
peak was much lower than for the formulations prepared in Tyrode’s solution. For the latter 
dispersant we obtained values that were similar to the ones for naked DNA in Tyrode. The 
ζ-potential distribution graphs for rM-β-CD/cholesterol/DNA in Tyrode and 
rM-β-CD/DC-cholesterol/DNA in both dispersants are given on figure 5.15. 
 
 
Figure 5.15: ζ-potential distribution of rM-β-CD/cholesterol/DNA in Tyrode and rM-β-CD/DC-cholesterol/DNA 
in water and Tyrode. 
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6 Discussion 
We investigated the size distribution profiles of various plasmid/vector associations recorded 
through Dynamic Light Scattering to characterize and evaluate these gene delivery systems. 
Depending on the different physicochemical properties of several non-viral carriers, 
advantages as well as limits of the technique were studied. Polycationic bPEI, monocationic 
poloxamine 304 and non-charged PE6400 were chosen as polymeric vector systems and 
single positively charged DC-cholesterol or uncharged cholesterol associated to rM-β-CD 
were evaluated as lipidic carriers.  
 
The technique of DLS offers many advantages. In general, nanoscopic particles as well as 
µm-sized ones may be investigated, whereas the Zetasizer Nano ZS is applicable from 0.6nm 
to 6µm. Structures of less than 2nm and associations of several µm in their hydrodynamic 
diameter were detected, making that wide size range valuable for our work. pCMVβGal itself 
shows a size well fitting for DLS experiments. Except for some large aggregates present in 
the rM-β-CD containing formulations, the carrier-associated structures to be measured within 
the different samples were of suitable size, either. 
Due to the feature of automatically or manual laser power regulation, diluted samples as well 
as highly concentrated ones may be measured. The plasmid concentration used for our 
investigations was chosen, since it needed to be applicable for in vivo investigations carried 
out besides the physicochemical characterization reported within this work (data not shown). 
As 150µl of each formulation were injected at once and 20µg of DNA were set as initial 
plasmid amount per injection, all the samples were prepared at a plasmid concentration of 
0.13µg/µl. Especially for the rM-β-CD and PE6400 containing systems we therefore had to 
work at the minimum concentration detectable by the device. Anyway, analyzable profiles 
were obtained, since the apparatus compensates low concentration by performing a greater 
number of measurements on one sample to statistically augment the reliability of the results. 
Further attention shall be paid to the high precision of the technique that was already useful 
when just measuring pCMVβGal itself: we detected variations between the size profiles 
obtained from the plasmid alone, purified by two different purification kits, although there 
were no differences visible from UV spectrophotometry and gel electrophoresis 
investigations. Thus, we may recommend additionally testing of DNA after its purification by 
DLS to verify its actual conformation.  
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Through DLS, the hydrodynamic diameters of the investigated DNA/vector associations are 
obtained, whereas different types of data may be consulted as results and quality criteria. 
Although almost all our samples, whatever they were composed of, showed a relatively high 
polydispersity index and more than just one size population, suitable data could be obtained. 
We did not rely onto the Z-average, as that parameter is mainly applicable for monodisperse 
samples. Instead, the size distribution profiles and the hydrodynamic diameters of each single 
peak were interpreted and evaluated.  
When comparing the profiles of the plasmid/vector associations to the ones obtained from 
DNA or the non-viral carrier alone, conclusions about the existence of interactions may be 
drawn. Thereby, the strength of the involved forces between the formed associations is 
assessable from the stability of the size peaks’ position and shape during the measurement of 
one sample. Reproducibility needs to be taken into account as well.  
To additionally prove the data, it is advisable to consult the correlograms which represent the 
raw material recorded by the device prior to any transformation by arithmetic operations. For 
small, rapidly moving particles, the correlation curve exhibits a fast decay rate, whereas for 
large particles the graph’s decay occurs on a much longer time scale, indicating slower 
diffusion rates. Thus, the information drawn from such curves are strongly associated to the 
ones obtained from the size distribution profiles. 
For bPEI/DNA and poloxamine 304/DNA, obviously different size distribution profiles were 
obtained when comparing them to the ones recorded for the polymer or DNA alone. Thus, 
relatively strong interactions that are well detectable by the technique may be indicated. 
However, the information that could be drawn from the investigation of the PE6400 and 
rM-β-CD containing formulations were not that clear. The hydrodynamic diameters of the 
non-viral carriers are of the same size range as DNA alone and the results obtained for the 
plasmid/vector associations strongly resembled the ones obtained for the plasmid, either. That 
behavior makes it impossible to conclude about the existence of interactions and restricts the 
use of DLS for our concerns. 
To gain further information, we investigated the plasmid/vector associations in several 
dispersants. The modifications within the samples are easily compensated through adaptations 
of the devices’ automatic calculation of the hydrodynamic diameter. Depending on the 
dispersant, differences in the size distribution profiles and the general comportment of the 
associated structures could be pointed out. 
We chose water as a non-ionic medium, NaCl 0.45% as an ionic solution of monocations and 
monoanions, and Tyrode, a physiological aqueous electrolyte additionally containing divalent 
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cations. There is no dispersant that may generally be considered as the optimal one, as that 
criterion depends on the presence of a gene delivery vector as well as on the vector type used 
to associate the plasmid. 
For DNA alone, an augmentation in ionic strength of the medium slightly stabilizes and 
homogenizes the size distribution profile, since homogeneity increased from water over NaCl 
0,45% to Tyrode’s solutions (to be seen as a decrease in the PDI value). That might be due to 
the overall ion concentration as well as to the presence of double positively charged ions. To 
further evaluate this hypothesis, another dispersant might be investigated, displaying the ionic 
force of Tyrode’s solution but resulting from monocations only. 
When DNA was attendant in the PE6400 or rM-β-CD containing formulations, similar results 
were obtained. However, for NaCl and Tyrode the peak of only a few nm, appearing for the 
vectors alone, was not detected anymore. In the presence of Tyrode, the mean count rate for 
these plasmid/vector associations was increased by up to 4-fold when compared to water. 
Thus, that peak might be masked, since its intensity is diminished relatively in comparison to 
the plasmid. As the profile of DNA underlay no changes, any interaction potential may be 
supposed. Another approach assumes PE6400 and the CDs to be arranged around the plasmid 
in Tyrode and thus, to be no more visible for the device as monomers. When following that 
assumption, especially in the ionic media interactions are considered to exist. The information 
obtained from DLS does not suffice to settle that question. 
For the CD-associated systems, the peaks generally displayed larger hydrodynamic diameters 
in Tyrode’s solution. Since the device does not measure the actual size of the systems, such 
differences might be due to an influence of the divalent cations onto the hydrodynamic 
conditions within the formulations. That may be proved as previously described for DNA 
alone.  
Variation of the medium most clearly affects the characteristics of the formulations containing 
poloxamine 304 or bPEI as non-viral carriers. For poloxamine 304/DNA, a strong influence 
of divalent cations is emphasized, as the size distribution profiles are similar for water and 
NaCl 0.45%, but clearly different for Tyrode’s solution. In water and NaCl, the smaller-sized 
of the two peaks clearly results from poloxamine 304, whereas the larger one resembles the 
major peak of naked DNA as well as the larger population of poloxamine 304 alone. Thus, we 
have to wonder if any complexation took place. Applying DLS investigations could not 
satisfyingly answer that question for these two dispersants, since an overlay between the 
peaks of the plasmids and of poloxamine 304 may exist. 
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However, in Tyrode’s solution, the size distribution profile differs completely. As only one 
peak was detected and since the PDI value was strongly decreased, the copolymer is indicated 
to better-associate to the DNA molecules. At a physiological pH, poloxamine 304 exhibits a 
single positive charge [25]. Thus, the divalent cations present in Tyrode might act as a third 
complexating partner and help the copolymer associating to the plasmid. 
Although some answers still lack, when interpreting all the results obtained for the different 
media, DLS gave insightful information concerning poloxamine 304/plasmid associations.  
For bPEI, we noticed the formation of relatively small complexes in water, whose 
hydrodynamic diameter is consistent with the results obtained by Tang and Szoka [76]. The 
complexes’ hydrodynamic diameter is smaller than for the plasmid alone, indicating 
successful complexation and compaction of pCMVβGal. bPEI efficiently complexes plasmid 
which results from electrostatic attraction forces between the negatively charged DNA 
molecules and polycationic bPEI, hampering dynamic movement within the samples. The 
hydrodynamic diameter of the complexes is to be seen advantageously for gene delivery, 
since the large size of DNA is one of the difficulties to overcome in gene therapy. Otherwise, 
the strong complexation could be a limiting factor as well, since the plasmid has to be 
released from the vector before its transcription into mRNA and its final expression. In 
contrast to the other systems, water was the only dispersant allowing bPEI/DNA complexes to 
display stable and homogeneous profiles. The presence of ions led to an important 
precipitation of the plasmid and to an increased hydrodynamic diameter of the polyplexes 
remaining in solution.  
We also investigated the influence of various DNA concentrations onto the systems. When 
working at the lower concentration limit detectable by the device, further dilution of the 
samples is not possible. In contrast, augmenting the plasmid concentration causes no 
problems. For the carriers that were already suggested to undergo little or no interactions with 
pCMVβGal (PE6400, rM-β-CD, rM-β-CD/cholesterol and rM-β-CD/DC-cholesterol), little 
differences in the size distribution profiles were detected when increasing DNA quantity 
within the samples. The influence of the plasmid concentration is more obvious when 
applying bPEI and poloxamine 304. For both, augmenting the DNA concentration leads to an 
increased hydrodynamic diameter, whereas for poloxamine 304, the same effect further 
occurred when decreasing the plasmid amounts. Concerning low DNA concentrations within 
the poloxamine 304 containing samples, the results of Pitard et al. [29] are consistent with 
our findings.  
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We examined, whether the increased diameter of the formulations containing higher DNA 
quantities results from a relative decrease in Tyrode’s salt concentration: apart from the 
reappearance of the poloxamine 304 peak at approximately 2.4nm and a general decrease in 
homogeneity, down to a Tyrode’s salt concentration of 0.5X no size shifts were detected. 
From our investigations, a minimum hydrodynamic size is found for 0.13µg/µl of 
pCMVβGal. However, to obtain a precise curve progression displaying the hydrodynamic 
size depending on the plasmid concentration, further samples of different quantitative 
compositions should be measured. 
As a further aspect, the reported observations concerning the effects after dilution of the 
rM-β-CD/cholesterol samples shall be mentioned. In comparison to the DC-cholesterol 
containing formulations, the samples show a different comportment when being diluted and 
thus, different phase solubility behaviors are suggested. Depending on the lipid, varying 
Higuchi diagrams are expected and consequently, better comprehension of those systems 
should be achieved by carrying out phase solubility experiments. 
To overall consider our examinations, it needs to be kept in mind that the device does not 
display the actual size of the particles, but their hydrodynamic diameter. That value 
corresponds to the diameter of the sphere, diffusing at the same speed as the sample being 
measured. 
Moreover, the shape of the systems under evaluation cannot be determined through the 
technique, making it necessary to additionally perform morphological analysis as cryo-TEM, 
for example. 
From such investigations we gained further information, broadening our idea of the 
plasmid/vector associations. As already established through DLS measurements, bPEI/DNA 
complexes formed in water were found to be well-compacted and smaller than 100nm. The 
detection of discrete dense structures and folded loops of DNA conforms to prior 
investigations [77]. For poloxamine 304, the results are consistent with those obtained by 
DLS, as well. Both techniques introduced the existence of two differently sized populations, 
but only cryo-TEM measurements allowed characterizing the particle’s surfaces, that varied 
for the two populations. In contrast, PE6400/plasmid associations display a more complex 
behavior and the structures observed through cryo-TEM investigations might be too dynamic 
to be evaluated with DLS. Until now, pCMVβGal alone was not analyzed through cryo-TEM. 
It is of particular interest to determine the influence of the medium onto the plasmid’s 
morphology alone, for the results may serve as a reference for the plasmid/vector associations. 
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Yet, micrographs of the CD containing formulations have not been recorded, either. Such 
investigations will obtain high priority in following experiments. 
 
When working with charged material, the surface potential of the structures importantly 
influences gene transfer’s efficiency and consequently, appropriate investigations are of 
particular interest. The Nernst potential itself cannot be examined, but as any relation between 
charged particles present in the same medium depends on the ζ-potential, we referred to that 
value.  
As expected, for pCMVβGal the ζ-potential is negative, since it displays a negatively charged 
phosphate backbone and the values become highly positive when the plasmid was complexed 
by an excess of bPEI. In accordance to the DLS results for bPEI/DNA, we obtained the 
highest data quality in water. 
For poloxamine 304/DNA associations, the ζ-potential was generally similar to the one of 
pure DNA, whereas it was much lower than for poloxamine 304 alone. These results suggest 
the presence of pCMVβGal at the surface of the particles when prepared in Tyrode. In water 
and NaCl, only very weak interactions may exist between poloxamine 304 and DNA, leading 
to a more complex behavior of those compounds. 
Measurements of the ζ-potential of PE6400/DNA associations confirmed the absence (or 
weakness) of complexation between the poloxamer and the DNA: the values obtained for both 
dispersants evaluated were strongly negative and similar to those of DNA alone. 
Since rM-β-CD does not display any charge, it was not surprising that we did neither in water 
nor in Tyrode’s solution succeed in determining a ζ-potential for the samples. For 
rM-β-CD/DC-cholesterol no ζ-potential could be measured, either. Unexpectedly, the 
apparatus succeeded in calculating a ζ-potential for the rM-β-CD/cholesterol samples, 
although both molecules do not display any charge. To explain that comportment, further 
examinations need to be carried out. 
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7 Conclusion 
DLS is a powerful technique that may be generally seen as useful in the characterization of 
interactions between plasmid and the investigated gene delivery vectors. Thereby, changes in 
the size distribution profile indicate interactions between the two components. From a small 
volume of little material concentration lots of information may be obtained, whereas the 
utility of the measurements to characterize the formulations depends on the carriers used to 
associate DNA. 
Especially for the vectors exhibiting electrostatic interactions with DNA, the method 
accurately describes the samples in various media and concentrations. For bPEI as well as for 
poloxamine 304 as complexation partners for pCMVβGal, an interaction potential was clearly 
visible from the resulting size distribution curves. We further succeeded in demonstrating, 
whether non-ionic or ionic dispersants should be preferred.  
In contrast, DLS does not display an ideal technique to investigate the comportment of DNA 
and vectors that are expected to undergo more dynamic interactions with the plasmid. The 
size distribution profiles of the PE6400 and rM-β-CD containing formulations strongly 
resembled the ones obtained for DNA alone. We well figured out the self-association 
behavior of the applied CDs, but with the help of DLS as sole technique, the actual existence 
of interactions between the plasmid and its non-ionic carriers cannot be clearly affirmed.  
However, DLS measurement may be used as a screening method to rapidly estimate the 
characteristics of the DNA/vector complexes, but anyway, a comprehensive study of the 
systems should comprise additional methods of evaluation. 
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